US20120078092A1 - Remotely imageable marker system and polysaccharide marker for use in same - Google Patents
Remotely imageable marker system and polysaccharide marker for use in same Download PDFInfo
- Publication number
- US20120078092A1 US20120078092A1 US13/301,297 US201113301297A US2012078092A1 US 20120078092 A1 US20120078092 A1 US 20120078092A1 US 201113301297 A US201113301297 A US 201113301297A US 2012078092 A1 US2012078092 A1 US 2012078092A1
- Authority
- US
- United States
- Prior art keywords
- marker
- polysaccharide
- intracorporeal
- binder
- members
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00898—Material properties expandable upon contact with fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3904—Markers, e.g. radio-opaque or breast lesions markers specially adapted for marking specified tissue
- A61B2090/3908—Soft tissue, e.g. breast tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3925—Markers, e.g. radio-opaque or breast lesions markers ultrasonic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3962—Markers, e.g. radio-opaque or breast lesions markers palpable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3987—Applicators for implanting markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
Definitions
- the invention is generally directed to remotely detectable, intracorporeal markers and devices and methods for the delivery of such markers to a desired location within a patient's body.
- obtaining a tissue sample by biopsy and the subsequent examination are typically employed in the diagnosis of cancers and other malignant tumors, or to confirm that a suspected lesion or tumor is not malignant.
- the information obtained from these diagnostic tests and/or examinations is frequently used to devise a therapeutic plan for the appropriate surgical procedure or other course of treatment.
- the suspicious tissue to be sampled is located in a subcutaneous site, such as inside a human breast.
- a small instrument such as a biopsy needle
- MRI magnetic resonance imaging
- tissue samples taken by biopsy is of particular significance in the diagnosis and treatment of breast cancer.
- the biopsy and treatment site described will generally be the human breast, although the invention is suitable for marking biopsy sites in other parts of the human and other mammalian body as well.
- Periodic physical examination of the breasts and mammography are important for early detection of potentially cancerous lesions.
- mammography the breast is compressed between two plates while specialized x-ray images are taken. If an abnormal mass in the breast is found by physical examination or mammography, ultrasound may be used to determine whether the mass is a solid tumor or a fluid-filled cyst. Solid masses are usually subjected to some type of tissue biopsy to determine if the mass is cancerous.
- a tissue specimen can be removed from the mass by a variety of techniques, including but not limited to open surgical biopsy, a technique known as Fine Needle Aspiration Biopsy (FNAB) and instruments characterized as “vacuum assisted large core biopsy devices”.
- open surgical biopsy a technique known as Fine Needle Aspiration Biopsy (FNAB) and instruments characterized as “vacuum assisted large core biopsy devices”.
- FNAB Fine Needle Aspiration Biopsy
- a vacuum assisted large core biopsy procedure is usually used.
- the patient lies on a special biopsy table with her breast compressed between the plates of a mammography apparatus and two separate x-rays or digital video views are taken from two different points of view.
- a computer calculates the exact position of the lesion as well as depth of the lesion within the breast.
- a mechanical stereotactic apparatus is programmed with the coordinates and depth information calculated by the computer, and such apparatus is used to precisely advance the biopsy needle into the small lesion.
- the stereotactic technique may be used to obtain histologic specimens. Usually at least five separate biopsy specimens are obtained from locations around the small lesion as well as one from the center of the lesion.
- the available treatment options for cancerous lesions of the breast include various degrees of mastectomy or lumpectomy, radiation therapy, chemotherapy and combinations of these treatments.
- radiographically visible tissue features originally observed in a mammogram, may be removed, altered or obscured by the biopsy procedure, and may heal or otherwise become altered following the biopsy.
- a biopsy site marker be placed in the patient's body to serve as a landmark for subsequent location of the lesion site.
- a biopsy site marker may be a permanent marker (e.g., a metal marker visible under x-ray examination), or a temporary marker (e.g., a bioresorbable marker detectable with ultrasound). While current radiographic type markers may persist at the biopsy site, an additional mammography generally must be performed at the time of follow up treatment or surgery in order to locate the site of the previous surgery or biopsy. In addition, once the site of the previous procedure is located using mammography, the site must usually be marked with a location wire which has a hook on the end which is advanced into site of the previous procedure. The hook is meant to fix the tip of the location wire with respect to the site of the previous procedure so that the patient can then be removed from the confinement of the mammography apparatus and the follow-up procedure performed.
- a permanent marker e.g., a metal marker visible under x-ray examination
- a temporary marker e.g., a bioresorbable marker detectable with ultrasound.
- the position of the location wire can change or shift in relation to the site of the previous procedure. This, in turn, can result in follow-up treatments being misdirected to an undesired portion of the patient's tissue.
- ultrasonic imaging herein abbreviated as “USI”
- USI ultrasonic imaging
- visualization techniques can be used to image the tissue of interest at the site of interest during a surgical or biopsy procedure or follow-up procedure.
- USI is capable of providing precise location and imaging of suspicious tissue, surrounding tissue and biopsy instruments within the patient's body during a procedure. Such imaging facilitates accurate and controllable removal or sampling of the suspicious tissue so as to minimize trauma to surrounding healthy tissue.
- the biopsy device is often imaged with USI while the device is being inserted into the patient's breast and activated to remove a sample of suspicious breast tissue.
- USI is often used to image tissue during follow-up treatment, it may be desirable to have a marker, similar to the radiographic markers discussed above, which can be placed in a patient's body at the site of a surgical procedure and which are visible using USI.
- a marker enables a follow-up procedure to be performed without the need for traditional radiographic mammography imaging which, as discussed above, can be subject to inaccuracies as a result of shifting of the location wire as well as being tedious and uncomfortable for the patient.
- Placement of a marker or multiple markers at a location within a patient's body requires delivery devices capable of holding markers within the device until the device is properly situated within a breast or other body location. Accordingly, devices and methods for retaining markers within a marker delivery device while allowing their expulsion from the devices at desired intracorporeal locations are desired.
- the invention is generally related to a remotely imageable marker system suitable for deployment at a site within a patient's body, particularly a biopsy site such as in a patient's breast.
- the invention in one form thereof, is directed to a remotely imageable marker system.
- the system includes a tubular delivery member having an inner lumen and a plurality of marker members.
- Each marker member of the plurality of marker members comprises a bioabsorbable polysaccharide in sufficient amount to exhibit hemostatic properties and a binder.
- the plurality of marker members is disposed within the inner lumen of the tubular delivery member.
- the invention in another form thereof, is directed to an intracorporeal marker for use in a remotely imageable marker system.
- the intracorporeal marker comprises a bioabsorbable body containing polysaccharide of a sufficient amount to exhibit hemostatic properties.
- the imageable marker system has a plurality of marker members containing polysaccharide in sufficient amounts to provide hemostatic properties and has a molecular weight of about 3500 to about 200,000 Daltons.
- the polysaccharide containing marker members are preferably press-formed from a dry powder into a pellet shape.
- the polysaccharide and binder powder may have a particle size of about 10 to about 200 micrometers.
- the polysaccharide markers rapidly absorb body fluid and hydrate and in the process dehydrate blood at the site of deployment to rapidly initiate clotting.
- the polysaccharide is preferably starch (corn starch or potato starch) but a variety of bioabsorbable polysaccharides are suitable, including glycogen, cellulose, chitin, chitosan, dextran, pectins, glucans, agar, alginate and carrageen.
- the binder is preferably methylcellulose but a variety of binders may be employed in lieu of or in addition to methylcellulose.
- Other suitable binders include hydroxyethyl cellulose, polyethylene glycol, polyvinyl alcohol, polyvinylpyrolidone.
- the remotely imageable marker system preferably includes a marker body with a radiopaque element connected thereto or incorporated therein to provide long term identification of the intracorporeal site.
- the radiopaque element is formed of non-magnetic material to avoid interference with magnetic resonance imaging (MRI). Suitable non-magnetic materials include titanium, platinum, gold, iridium, tantalum, tungsten, silver, rhodium, non-magnetic stainless steel ( 316 ) and the like.
- the radiopaque element should have a shape that is readily recognized at the intracorporeal site when remotely imaged.
- the radiopaque element should have a maximum dimension of about 0.5 to about 5 mm, preferably about 1 to about 3 mm to ensure remote identification, particularly with MRI.
- the marker body having a radiopaque element is preferably formed of a bioabsorbable polymeric material such as polylactic-polyglycolic acid (polylactide-co-glycolide) with a longer dissolution time than the polysaccharide pellets, although the latter may be used.
- a bioabsorbable polymeric material such as polylactic-polyglycolic acid (polylactide-co-glycolide) with a longer dissolution time than the polysaccharide pellets, although the latter may be used.
- the polysaccharide containing pellets will generally have a transverse dimension of about 0.02 to about 0.1 inch (0.5-2.5 mm), preferably about 0.035 to about 0.075 inch (0.9-1.9 mm), and typically about 0.056 inch (1.4 mm).
- the pellets will have a length of about 0.1 to about 0.4 inch (2.5-10 mm), preferably about 0.15 to about 0.35 inch (3.8-8.9 mm).
- the pellets provide sufficient column strength to facilitate introduction into and discharge thereof from the tubular delivery device.
- the markers are preferably arranged for delivery within the delivery tube with the marker having a radiopaque element between two adjacent marker members formed of polysaccharide. As presently contemplated, within the delivery tube there will be two polysaccharide marker members distal and two polysaccharide marker members proximal to the marker having a radiopaque element.
- the marker member embodying features of the invention can be readily delivered to the desired location by suitable delivery systems such as disclosed in applications Ser. No. 10/444,770, filed on May 23, 2003, now U.S. Pat. No. 7,983,734 B2, and Ser. No. 10/753,694, filed Jan. 7, 2004.
- the marker delivery system generally has an elongated cannula or tube with proximal and distal ports and an inner lumen extending between the ports.
- the marker member is slidably disposed within the inner lumen of the delivery cannula and a plunger slidably disposed within the inner lumen of the delivery cannula proximal to the markers.
- the plunger is movable from an initial position proximal to the markers within the tube, to a delivery position close to the discharge opening in the distal end of the cannula to push the marker members out of the discharge opening into the target tissue site.
- the plurality of polysaccharide containing markers Upon being discharged into the intracorporeal target site, the plurality of polysaccharide containing markers quickly take up body fluid at the site, initiating the clotting process and providing hemostasis.
- the other marker member with a radiopaque marker element enables short term detection (at least three weeks, preferably at least four weeks but less than a year) by remote USI and preferably long term detection by remote mammographic imaging or MRI identification by the radiopaque element.
- the polysaccharide bodies dissolve in situ in about five seconds to about 2 minutes and enzymatically degrade in about 2-5 days.
- the cannula of the marker delivery device may be configured to fit within the guide cannula of a biopsy device, such as a Mammotome® (sold by Johnson & Johnson), the SenoCor 360TM biopsy device sold by SenoRx (the present assignee), the EnCorTM biopsy device sold by SenoRx and or a coaxial needle guide.
- the delivery cannula can also be configured to fit into the proximal end of a tubular cutting element such as found in the EnCorTM biopsy system sold by SenoRx which is the subject of co-pending application Ser. No. 10/911,106, filed on Aug. 3, 2004.
- One suitable delivery system suitable for delivery through a tubular cutter is a syringe-type delivery system described in co-pending application Ser. No. 10/911,106, filed on Aug. 3, 2004 having a tubular shaft with a flared guide on or integral with the distal tip to facilitate engagement with the proximal end of the tubular cutter.
- Another syringe-type delivery system has a plugged distal tip to prevent body fluids from engaging one or more markers which may be in the tubular shaft of the delivery system. Such fluid infusions can retard or restrict discharging the markers within the inner lumen of the delivery cannula by causing the markers to take up water or swell within the lumen of the delivery cannula.
- the plugged tip type delivery systems can have a side opening for marker deployment or a plugged needle-type distal tip both of which are disclosed in the above application Ser. No. 10/753,694.
- a variety of therapeutic or diagnostic agents may also be incorporated into the marker bodies.
- Incorporated agents can include for example, anesthetic agents to control pain, chemotherapeutic agents for treating residual neoplastic tissue or coloring agents to facilitate subsequent visual location of the site.
- Antibiotics, antifungal agents and antiviral agents may also be incorporated into the marker bodies.
- the markers Upon delivery to the intracorporeal site, the markers are easily identifiable from surrounding tissue at the site by ultrasonic imaging (USI).
- USI ultrasonic imaging
- the polysaccharide containing markers embodying features of the present invention provide several advantages.
- the polysaccharide marker bodies quickly dissolve in the body fluids at the site to provide to provide rapid hemostasis therein even with serious bleeding.
- the materials rapidly degrade so there is no long term irritation or inflammation at the site.
- FIG. 1 is a plan view of a press-formed marker member embodying features of the invention.
- FIG. 2 is an end view of the marker member shown in FIG. 1 .
- FIG. 3 is a perspective view of a plurality of markers arranged as they would be within a delivery tube (not shown).
- FIG. 4 is a partly cut-away perspective view of a marker delivery assembly having a plurality of marker members embodying features of the invention.
- FIG. 5 is a transverse cross-sectional view taken along the lines 5 - 5 shown in FIG. 4 .
- FIGS. 1 and 2 illustrate a press-formed marker member 10 embodying features of the invention which is formed of a mixture of polysaccharide powder and methylcellulose powder.
- the press-formed marker member 10 has sufficient polysaccharide powder so as to quickly form thrombus when coming into contact with blood at an intracorporeal site.
- the marker member 10 will have 65% (by wt.) polysaccharide and 35% (by wt.) methylcellulose.
- the marker member 10 is preferably formed by mixing polysaccharide powder (corn starch or potato starch) and methylcellulose powder in appropriate amounts, placing the mixed powder in a pellet die and subjecting the powder within the pellet die to a pressure of about 6 to 40 ksi, typically about 12 ksi.
- One suitable polysaccharide material is U.S.P. Topical Starch.
- HemadermTM which is available from Medafor, Inc. located in Minneapolis, Minn., may also be used. This product is described at least in part in U.S. Pat. No. 6,060,461.
- the marker member 10 may be formed in a variety of shapes and sizes, but generally the length of the marker member is at least twice, preferably five times that of the maximum transverse dimension.
- the marker member 10 should have sufficient column strength to allow it to be pushed within the delivery tube without significant damage.
- the marker member may be partially or completely coated with a bioabsorbable polymeric material such as polylactic acid, polyglycolic acid and copolymers thereof to control the dissolution of the material of the marker member.
- FIGS. 4 and 5 One suitable marker delivery system 15 is depicted in FIGS. 4 and 5 which includes a delivery tube or cannula 16 with an inner lumen 17 , a distal portion 18 , and a proximal portion 19 with a handle 20 .
- a releasable distal plug 21 and the press-formed markers 10 are shown disposed within the inner lumen 17 .
- a marker body 22 formed of a bioabsorbable material other than a polysaccharide with a radiopaque element is disposed between at least two press-formed marker bodies 10 .
- a plunger 23 is slidably disposed within the inner lumen 17 and is provided with a head 24 on the proximal end 25 configured to allow an operator to press the plunger further into the inner lumen and push both the releasable plug 21 and marker members 10 and marker body 22 out of the discharge port or opening 26 in the distal end 27 of delivery cannula 16 .
- Cannula handle 20 allows an operator to hold the cannula steady while pressing plunger 23 to discharge the releasable plug 21 and marker members 10 and marker body 22 .
- Releasable plug 21 may substantially fill the discharge opening 26 , as shown in FIG. 4 or at least occupy or block a portion of the discharge opening.
- the exposed face of plug 21 is preferably provided with an inclined configuration.
- Releasable plug 21 is configured to be tight enough, e.g. press fit, in the inner lumen 17 to prevent its inadvertent release which might allow premature discharge of marker 10 from delivery cannula 16 , but the plug must be easily released when the plunger 23 is pressed deeper into the inner lumen 17 of the delivery cannula 16 .
- An adhesive or mechanical element(s) may be used to hold the releasable plug 21 in a position within the inner lumen 17 to occlude the discharge opening 26 .
- Suitable adhesives include polyurethane or polyacrylic based adhesives, polyhydroxymethacrylate base adhesives, fibrin glue (e.g., TissealTM), collagen adhesive, or mixtures thereof.
- Suitable mechanical means for securing the releasable plug 21 are described in application Ser. No. 10/174,401, now U.S. Pat. No. 7,651,505.
- the distal end 26 of the delivery cannula 16 is provided with a ramp 27 which guides the discharged plug 21 and marker member 10 out of the side port 28 into the target site.
- the distal tip 29 may be tapered for delivery through a guide tube (not shown).
- the delivery cannula 16 may be provided with markings 30 which serve as visual landmarks to aid an operator in accurately placing the distal portion 18 of the cannula 16 in a desired location within a patient's body for discharging the marker 10 .
- the exterior of the delivery cannula 16 is preferably configured to fit within a guide cannula sized to accept a SenoCor®, EnCorTM, Mammotome® or Tru-Cut®, biopsy device.
- plug 21 and marker member 10 will have diameters determined by the size of the inner lumen 17 and typically will be about 0.02 inch (0.5 mm) to about 0.5 inch (12 mm), preferably about 0.04 inch (1 mm) to about 0.3 inch (8 mm). Plug 21 may have slightly larger transverse dimensions to provide a tight fit.
- the binding agent When the marker member 10 contacts body fluid within a body cavity such as a lumpectomy or biopsy site, the binding agent is dissolved and the polysaccharide draws moisture away from the blood and other fluids at the site and the clotting cascade begins to form thrombus at the site resulting in hemostasis.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Abstract
A remotely imageable marker system includes a tubular delivery member having an inner lumen and a plurality of marker members. Each marker member of the plurality of marker members comprises a bioabsorbable polysaccharide in sufficient amount to exhibit hemostatic properties and a binder. The plurality of marker members is disposed within the inner lumen of the tubular delivery member.
Description
- This application is a continuation-in-part of U.S. patent application Ser. No. 12/070,787, entitled “POLYSACCHARIDE MARKERS”, filed Feb. 21, 2008, which is a continuation-in-part of U.S. patent application Ser. No. 11/881,264, filed Jul. 26, 2007, which is related to and claims priority from provisional application Ser. No. 60/835,740, filed on Aug. 4, 2006.
- Also, this application is a continuation-in-part of U.S. patent application Ser. No. 13/155,628 entitled “FIBROUS MARKER AND INTRACORPOREAL DELIVERY THEREOF”, filed Jun. 8, 2011, which is a continuation of U.S. patent application Ser. No. 10/444,770, filed May 23, 2003, now U.S. Pat. No. 7,983,734 B2.
- Also, this application is a continuation-in-part of U.S. patent application Ser. No. 13/037,971 entitled “MARKER DELIVERY DEVICE WITH RELEASABLE PLUG”, filed Mar. 1, 2011, which is a continuation-in-part of U.S. patent application Ser. No. 10/753,694, filed Jan. 7, 2004, now abandoned, which is a continuation-in-part of U.S. patent application Ser. No. 10/444,770, filed May 23, 2003, now U.S. Pat. No. 7,983,734 B2.
- Also, this application is a continuation-in-part of U.S. patent application Ser. No. 12/852,286 entitled CAVITY-FILLING BIOPSY SITE MARKERS, filed Aug. 6, 2010, which is a continuation of U.S. patent application Ser. No. 10/990,327, filed Nov. 16, 2004, now U.S. Pat. No. 7,792,569, which is a continuation of U.S. patent application Ser. No. 10/124,757, filed Apr. 16, 2002, now U.S. Pat. No. 6,862,470, which is a continuation-in-part of U.S. patent application Ser. No. 09/717,909, filed Nov. 20, 2000, now U.S. Pat. No. 6,725,083, which is a continuation-in-part of U.S. patent application Ser. No. 09/343,975, filed Jun. 30, 1999, now U.S. Pat. No. 6,347,241, which is a continuation-in-part of U.S. patent application Ser. No. 09/241,936, filed Feb. 2, 1999, now U.S. Pat. No. 6,161,034.
- Also, this application is a continuation-in-part of U.S. patent application Ser. No. 12/592,020 entitled PLUGGED TIP DELIVERY TUBE FOR MARKER PLACEMENT, filed Nov. 18, 2009, which is a continuation of U.S. patent application Ser. No. 10/174,401, filed Jun. 17, 2002, now U.S. Pat. No. 7,651,505.
- Also, this application is a continuation-in-part of U.S. patent application Ser. No. 10/911,106 entitled BIOPSY DEVICE WITH SELECTABLE TISSUE RECEIVING APERTURE ORIENTATION AND SITE ILLUMINATION, filed Aug. 3, 2004, which is a continuation-in-part of U.S. patent application Ser. No. 10/642,406, filed Aug. 15, 2003, now U.S. Pat. No. 7,819,819, which is a continuation-in-part of U.S. patent application Ser. No. 10/374,915, filed Feb. 24, 2003, now U.S. Pat. No. 7,189,206.
- All the above from which priority is claimed are incorporated herein by reference in their entireties.
- The invention is generally directed to remotely detectable, intracorporeal markers and devices and methods for the delivery of such markers to a desired location within a patient's body.
- In diagnosing and treating certain medical conditions, it is often desirable to mark a suspicious body site for the subsequent taking of a biopsy specimen, for delivery of medicine, radiation, or other treatment, for the relocation of a site from which a biopsy specimen was taken, or at which some other procedure was performed. As is known, obtaining a tissue sample by biopsy and the subsequent examination are typically employed in the diagnosis of cancers and other malignant tumors, or to confirm that a suspected lesion or tumor is not malignant. The information obtained from these diagnostic tests and/or examinations is frequently used to devise a therapeutic plan for the appropriate surgical procedure or other course of treatment.
- In many instances, the suspicious tissue to be sampled is located in a subcutaneous site, such as inside a human breast. To minimize surgical intrusion into a patient's body, it is often desirable to insert a small instrument, such as a biopsy needle, into the body for extracting the biopsy specimen while imaging the procedure using fluoroscopy, ultrasonic imaging, x-rays, magnetic resonance imaging (MRI) or any other suitable form of imaging technique or palpation. Examination of tissue samples taken by biopsy is of particular significance in the diagnosis and treatment of breast cancer. In the ensuing discussion, the biopsy and treatment site described will generally be the human breast, although the invention is suitable for marking biopsy sites in other parts of the human and other mammalian body as well.
- Periodic physical examination of the breasts and mammography are important for early detection of potentially cancerous lesions. In mammography, the breast is compressed between two plates while specialized x-ray images are taken. If an abnormal mass in the breast is found by physical examination or mammography, ultrasound may be used to determine whether the mass is a solid tumor or a fluid-filled cyst. Solid masses are usually subjected to some type of tissue biopsy to determine if the mass is cancerous.
- If a solid mass or lesion is large enough to be palpable, a tissue specimen can be removed from the mass by a variety of techniques, including but not limited to open surgical biopsy, a technique known as Fine Needle Aspiration Biopsy (FNAB) and instruments characterized as “vacuum assisted large core biopsy devices”.
- If a solid mass of the breast is small and non-palpable (e.g., the type typically discovered through mammography), a vacuum assisted large core biopsy procedure is usually used. In performing a stereotactic biopsy of a breast, the patient lies on a special biopsy table with her breast compressed between the plates of a mammography apparatus and two separate x-rays or digital video views are taken from two different points of view. A computer calculates the exact position of the lesion as well as depth of the lesion within the breast. Thereafter, a mechanical stereotactic apparatus is programmed with the coordinates and depth information calculated by the computer, and such apparatus is used to precisely advance the biopsy needle into the small lesion. The stereotactic technique may be used to obtain histologic specimens. Usually at least five separate biopsy specimens are obtained from locations around the small lesion as well as one from the center of the lesion.
- The available treatment options for cancerous lesions of the breast include various degrees of mastectomy or lumpectomy, radiation therapy, chemotherapy and combinations of these treatments. However, radiographically visible tissue features, originally observed in a mammogram, may be removed, altered or obscured by the biopsy procedure, and may heal or otherwise become altered following the biopsy. In order for the surgeon or radiation oncologist to direct surgical or radiation treatment to the precise location of the breast lesion several days or weeks after the biopsy procedure was performed, it is desirable that a biopsy site marker be placed in the patient's body to serve as a landmark for subsequent location of the lesion site. A biopsy site marker may be a permanent marker (e.g., a metal marker visible under x-ray examination), or a temporary marker (e.g., a bioresorbable marker detectable with ultrasound). While current radiographic type markers may persist at the biopsy site, an additional mammography generally must be performed at the time of follow up treatment or surgery in order to locate the site of the previous surgery or biopsy. In addition, once the site of the previous procedure is located using mammography, the site must usually be marked with a location wire which has a hook on the end which is advanced into site of the previous procedure. The hook is meant to fix the tip of the location wire with respect to the site of the previous procedure so that the patient can then be removed from the confinement of the mammography apparatus and the follow-up procedure performed. However, as the patient is removed from the mammography apparatus, or otherwise transported the position of the location wire can change or shift in relation to the site of the previous procedure. This, in turn, can result in follow-up treatments being misdirected to an undesired portion of the patient's tissue.
- As an alternative or adjunct to radiographic imaging, ultrasonic imaging (herein abbreviated as “USI”) or visualization techniques can be used to image the tissue of interest at the site of interest during a surgical or biopsy procedure or follow-up procedure. USI is capable of providing precise location and imaging of suspicious tissue, surrounding tissue and biopsy instruments within the patient's body during a procedure. Such imaging facilitates accurate and controllable removal or sampling of the suspicious tissue so as to minimize trauma to surrounding healthy tissue.
- For example, during a breast biopsy procedure, the biopsy device is often imaged with USI while the device is being inserted into the patient's breast and activated to remove a sample of suspicious breast tissue. As USI is often used to image tissue during follow-up treatment, it may be desirable to have a marker, similar to the radiographic markers discussed above, which can be placed in a patient's body at the site of a surgical procedure and which are visible using USI. Such a marker enables a follow-up procedure to be performed without the need for traditional radiographic mammography imaging which, as discussed above, can be subject to inaccuracies as a result of shifting of the location wire as well as being tedious and uncomfortable for the patient.
- Placement of a marker or multiple markers at a location within a patient's body requires delivery devices capable of holding markers within the device until the device is properly situated within a breast or other body location. Accordingly, devices and methods for retaining markers within a marker delivery device while allowing their expulsion from the devices at desired intracorporeal locations are desired.
- In addition to marking functions, frequently it is desirable to provide treatments with the marker members such as hemostatic treatment and the like.
- The invention is generally related to a remotely imageable marker system suitable for deployment at a site within a patient's body, particularly a biopsy site such as in a patient's breast.
- The invention, in one form thereof, is directed to a remotely imageable marker system. The system includes a tubular delivery member having an inner lumen and a plurality of marker members. Each marker member of the plurality of marker members comprises a bioabsorbable polysaccharide in sufficient amount to exhibit hemostatic properties and a binder. The plurality of marker members is disposed within the inner lumen of the tubular delivery member.
- The invention, in another form thereof, is directed to an intracorporeal marker for use in a remotely imageable marker system. The intracorporeal marker comprises a bioabsorbable body containing polysaccharide of a sufficient amount to exhibit hemostatic properties.
- In some embodiments, the imageable marker system has a plurality of marker members containing polysaccharide in sufficient amounts to provide hemostatic properties and has a molecular weight of about 3500 to about 200,000 Daltons. The polysaccharide containing marker members are preferably press-formed from a dry powder into a pellet shape. The polysaccharide and binder powder may have a particle size of about 10 to about 200 micrometers. The polysaccharide markers rapidly absorb body fluid and hydrate and in the process dehydrate blood at the site of deployment to rapidly initiate clotting.
- The polysaccharide is preferably starch (corn starch or potato starch) but a variety of bioabsorbable polysaccharides are suitable, including glycogen, cellulose, chitin, chitosan, dextran, pectins, glucans, agar, alginate and carrageen. The binder is preferably methylcellulose but a variety of binders may be employed in lieu of or in addition to methylcellulose. Other suitable binders include hydroxyethyl cellulose, polyethylene glycol, polyvinyl alcohol, polyvinylpyrolidone.
- The remotely imageable marker system preferably includes a marker body with a radiopaque element connected thereto or incorporated therein to provide long term identification of the intracorporeal site. Preferably, the radiopaque element is formed of non-magnetic material to avoid interference with magnetic resonance imaging (MRI). Suitable non-magnetic materials include titanium, platinum, gold, iridium, tantalum, tungsten, silver, rhodium, non-magnetic stainless steel (316) and the like. The radiopaque element should have a shape that is readily recognized at the intracorporeal site when remotely imaged. The radiopaque element should have a maximum dimension of about 0.5 to about 5 mm, preferably about 1 to about 3 mm to ensure remote identification, particularly with MRI. The marker body having a radiopaque element is preferably formed of a bioabsorbable polymeric material such as polylactic-polyglycolic acid (polylactide-co-glycolide) with a longer dissolution time than the polysaccharide pellets, although the latter may be used.
- The polysaccharide containing pellets will generally have a transverse dimension of about 0.02 to about 0.1 inch (0.5-2.5 mm), preferably about 0.035 to about 0.075 inch (0.9-1.9 mm), and typically about 0.056 inch (1.4 mm). The pellets will have a length of about 0.1 to about 0.4 inch (2.5-10 mm), preferably about 0.15 to about 0.35 inch (3.8-8.9 mm). The pellets provide sufficient column strength to facilitate introduction into and discharge thereof from the tubular delivery device. The markers are preferably arranged for delivery within the delivery tube with the marker having a radiopaque element between two adjacent marker members formed of polysaccharide. As presently contemplated, within the delivery tube there will be two polysaccharide marker members distal and two polysaccharide marker members proximal to the marker having a radiopaque element.
- The marker member embodying features of the invention can be readily delivered to the desired location by suitable delivery systems such as disclosed in applications Ser. No. 10/444,770, filed on May 23, 2003, now U.S. Pat. No. 7,983,734 B2, and Ser. No. 10/753,694, filed Jan. 7, 2004. The marker delivery system generally has an elongated cannula or tube with proximal and distal ports and an inner lumen extending between the ports. The marker member is slidably disposed within the inner lumen of the delivery cannula and a plunger slidably disposed within the inner lumen of the delivery cannula proximal to the markers. The plunger is movable from an initial position proximal to the markers within the tube, to a delivery position close to the discharge opening in the distal end of the cannula to push the marker members out of the discharge opening into the target tissue site.
- Upon being discharged into the intracorporeal target site, the plurality of polysaccharide containing markers quickly take up body fluid at the site, initiating the clotting process and providing hemostasis. The other marker member with a radiopaque marker element enables short term detection (at least three weeks, preferably at least four weeks but less than a year) by remote USI and preferably long term detection by remote mammographic imaging or MRI identification by the radiopaque element. Typically, the polysaccharide bodies dissolve in situ in about five seconds to about 2 minutes and enzymatically degrade in about 2-5 days.
- The cannula of the marker delivery device may be configured to fit within the guide cannula of a biopsy device, such as a Mammotome® (sold by Johnson & Johnson), the SenoCor 360™ biopsy device sold by SenoRx (the present assignee), the EnCor™ biopsy device sold by SenoRx and or a coaxial needle guide. The delivery cannula can also be configured to fit into the proximal end of a tubular cutting element such as found in the EnCor™ biopsy system sold by SenoRx which is the subject of co-pending application Ser. No. 10/911,106, filed on Aug. 3, 2004.
- One suitable delivery system suitable for delivery through a tubular cutter (e.g. as with the Encor™ system) is a syringe-type delivery system described in co-pending application Ser. No. 10/911,106, filed on Aug. 3, 2004 having a tubular shaft with a flared guide on or integral with the distal tip to facilitate engagement with the proximal end of the tubular cutter. Another syringe-type delivery system has a plugged distal tip to prevent body fluids from engaging one or more markers which may be in the tubular shaft of the delivery system. Such fluid infusions can retard or restrict discharging the markers within the inner lumen of the delivery cannula by causing the markers to take up water or swell within the lumen of the delivery cannula. Delivery systems with plugged tips are described in applications Ser. No. 10/444,770, filed on May 23, 2003, now U.S. Pat. No. 7,983,734 B2, and Ser. No. 10/753,277, filed on Dec. 23, 2003, which are incorporated herein in their entireties. The plugged tip type delivery systems can have a side opening for marker deployment or a plugged needle-type distal tip both of which are disclosed in the above application Ser. No. 10/753,694.
- A variety of therapeutic or diagnostic agents may also be incorporated into the marker bodies. Incorporated agents can include for example, anesthetic agents to control pain, chemotherapeutic agents for treating residual neoplastic tissue or coloring agents to facilitate subsequent visual location of the site. Antibiotics, antifungal agents and antiviral agents may also be incorporated into the marker bodies.
- Upon delivery to the intracorporeal site, the markers are easily identifiable from surrounding tissue at the site by ultrasonic imaging (USI).
- The polysaccharide containing markers embodying features of the present invention provide several advantages. The polysaccharide marker bodies quickly dissolve in the body fluids at the site to provide to provide rapid hemostasis therein even with serious bleeding. Moreover, the materials rapidly degrade so there is no long term irritation or inflammation at the site.
- These and other advantages of the invention will become more apparent from the following detailed description of embodiments when taken in conjunction with the accompanying exemplary drawings.
-
FIG. 1 is a plan view of a press-formed marker member embodying features of the invention. -
FIG. 2 is an end view of the marker member shown inFIG. 1 . -
FIG. 3 is a perspective view of a plurality of markers arranged as they would be within a delivery tube (not shown). -
FIG. 4 is a partly cut-away perspective view of a marker delivery assembly having a plurality of marker members embodying features of the invention. -
FIG. 5 is a transverse cross-sectional view taken along the lines 5-5 shown inFIG. 4 . -
FIGS. 1 and 2 illustrate a press-formedmarker member 10 embodying features of the invention which is formed of a mixture of polysaccharide powder and methylcellulose powder. The press-formedmarker member 10 has sufficient polysaccharide powder so as to quickly form thrombus when coming into contact with blood at an intracorporeal site. Typically, themarker member 10 will have 65% (by wt.) polysaccharide and 35% (by wt.) methylcellulose. Themarker member 10 is preferably formed by mixing polysaccharide powder (corn starch or potato starch) and methylcellulose powder in appropriate amounts, placing the mixed powder in a pellet die and subjecting the powder within the pellet die to a pressure of about 6 to 40 ksi, typically about 12 ksi. - One suitable polysaccharide material is U.S.P. Topical Starch. Alternatively, Hemaderm™, which is available from Medafor, Inc. located in Minneapolis, Minn., may also be used. This product is described at least in part in U.S. Pat. No. 6,060,461.
- The
marker member 10 may be formed in a variety of shapes and sizes, but generally the length of the marker member is at least twice, preferably five times that of the maximum transverse dimension. Themarker member 10 should have sufficient column strength to allow it to be pushed within the delivery tube without significant damage. In some instances the marker member may be partially or completely coated with a bioabsorbable polymeric material such as polylactic acid, polyglycolic acid and copolymers thereof to control the dissolution of the material of the marker member. - One suitable
marker delivery system 15 is depicted inFIGS. 4 and 5 which includes a delivery tube orcannula 16 with aninner lumen 17, adistal portion 18, and aproximal portion 19 with ahandle 20. A releasabledistal plug 21 and the press-formedmarkers 10 are shown disposed within theinner lumen 17. Amarker body 22 formed of a bioabsorbable material other than a polysaccharide with a radiopaque element is disposed between at least two press-formedmarker bodies 10. Aplunger 23 is slidably disposed within theinner lumen 17 and is provided with ahead 24 on theproximal end 25 configured to allow an operator to press the plunger further into the inner lumen and push both thereleasable plug 21 andmarker members 10 andmarker body 22 out of the discharge port or opening 26 in thedistal end 27 ofdelivery cannula 16. Cannula handle 20 allows an operator to hold the cannula steady while pressingplunger 23 to discharge thereleasable plug 21 andmarker members 10 andmarker body 22. -
Releasable plug 21, preferably formed of polyethylene glycol, may substantially fill thedischarge opening 26, as shown inFIG. 4 or at least occupy or block a portion of the discharge opening. The exposed face ofplug 21 is preferably provided with an inclined configuration.Releasable plug 21 is configured to be tight enough, e.g. press fit, in theinner lumen 17 to prevent its inadvertent release which might allow premature discharge ofmarker 10 fromdelivery cannula 16, but the plug must be easily released when theplunger 23 is pressed deeper into theinner lumen 17 of thedelivery cannula 16. An adhesive or mechanical element(s) may be used to hold thereleasable plug 21 in a position within theinner lumen 17 to occlude thedischarge opening 26. Suitable adhesives include polyurethane or polyacrylic based adhesives, polyhydroxymethacrylate base adhesives, fibrin glue (e.g., Tisseal™), collagen adhesive, or mixtures thereof. Suitable mechanical means for securing thereleasable plug 21 are described in application Ser. No. 10/174,401, now U.S. Pat. No. 7,651,505. Thedistal end 26 of thedelivery cannula 16 is provided with aramp 27 which guides the dischargedplug 21 andmarker member 10 out of theside port 28 into the target site. Thedistal tip 29 may be tapered for delivery through a guide tube (not shown). - The
delivery cannula 16 may be provided withmarkings 30 which serve as visual landmarks to aid an operator in accurately placing thedistal portion 18 of thecannula 16 in a desired location within a patient's body for discharging themarker 10. - The exterior of the
delivery cannula 16 is preferably configured to fit within a guide cannula sized to accept a SenoCor®, EnCor™, Mammotome® or Tru-Cut®, biopsy device. Typically, plug 21 andmarker member 10 will have diameters determined by the size of theinner lumen 17 and typically will be about 0.02 inch (0.5 mm) to about 0.5 inch (12 mm), preferably about 0.04 inch (1 mm) to about 0.3 inch (8 mm).Plug 21 may have slightly larger transverse dimensions to provide a tight fit. - When the
marker member 10 contacts body fluid within a body cavity such as a lumpectomy or biopsy site, the binding agent is dissolved and the polysaccharide draws moisture away from the blood and other fluids at the site and the clotting cascade begins to form thrombus at the site resulting in hemostasis. - While one or more particular forms of the invention have been illustrated and described herein in the context of a breast biopsy site, it will be apparent that the device and methods having features of the invention may find use in a variety of locations and in a variety of applications, in addition to the human breast, where tissue has been removed. Moreover, various modifications can be made without departing from the spirit and scope of the invention. For example, while the polysaccharide bodies are primarily described herein as press-formed bodies, the polysaccharide materials by be encapsulated in a bioabsorbable body or be in other forms. Accordingly, it is not intended that the invention be limited to the specific embodiments illustrated. It is therefore intended that this invention to be defined by the scope of the appended claims as broadly as the prior art will permit, and in view of the specification if need be. Moreover, those skilled in the art will recognize that features shown in one embodiment may be utilized in other embodiments. Additional details of pellet or other marker members and delivery systems may be found in applications Ser. No. 10/753,694, filed on Jan. 7, 2004, and Ser. No. 10/976,138, filed on Oct. 27, 2004.
- Terms such as “element”, “member”, “device”, “section”, “portion”, “step”, “means” and words of similar import when used in the following claims shall not be construed as invoking the provisions of 35 U.S.C. §112(6) unless the following claims expressly use the term “means” followed by a particular function without specific structure or expressly use the term “step” followed by a particular function without specific action. All patents and patent applications referred to above are hereby incorporated by reference in their entirety.
Claims (20)
1. A remotely imageable marker system, comprising:
a tubular delivery member having an inner lumen; and
a plurality of marker members, each marker member of the plurality of marker members comprising a bioabsorbable polysaccharide in sufficient amount to exhibit hemostatic properties and a binder, the plurality of marker members being disposed within the inner lumen of the tubular delivery member.
2. The system of claim 1 , wherein each marker member of the plurality of marker members contains about 10 to about 90% (by wt.) bioabsorbable polysaccharide.
3. The system of claim 2 , wherein the polysaccharide is selected from a group consisting of starch, glycogen, cellulose, chitin, chitosan, dextran, pectins, glucans, agar, alginate and carrageen.
4. The system of claim 2 , wherein the polysaccharide is corn starch or potato starch.
5. The system of claim 1 , wherein each marker member of the plurality of marker members contains about 10 to about 90% (by wt.) binder.
6. The system of claim 1 , wherein the binder is selected from a group consisting of methylcellulose, hydroxyethyl cellulose, polyethylene glycol, polyvinyl alcohol, polyvinylpyrolidone.
7. The system of claim 1 , wherein the binder comprises methylcellulose.
8. The system of claim 1 , wherein at least one marker member of the plurality of marker members is a press-formed marker member having a desired shape.
9. The system of claim 1 , wherein a radiopaque marker element is disposed between two marker members formed of polysaccharide.
10. The system of claim 1 , wherein two marker members formed of polysaccharide are disposed distal to a marker body having a radiopaque marker element contained therein.
11. The system of claim 1 , wherein two marker members formed of polysaccharide are disposed proximal to a marker body having a radiopaque marker element contained therein.
12. An intracorporeal marker for use in a remotely imageable marker system, the intracorporeal marker comprising a bioabsorbable body containing polysaccharide of a sufficient amount to exhibit hemostatic properties.
13. The intracorporeal marker of claim 12 , wherein the bioabsorbable body is a press-formed body that contains about 10 to about 90% (by wt.) bioabsorbable polysaccharide and a binder.
14. The intracorporeal marker of claim 12 , wherein the polysaccharide is selected from a group consisting of starch, glycogen, cellulose, chitin, chitosan, dextran, pectins, glucans, agar, alginate and carrageen.
15. The intracorporeal marker of claim 12 , wherein the polysaccharide is corn starch or potato starch.
16. The intracorporeal marker of claim 12 , wherein the bioabsorbable body is a press-formed body that contains about 10 to about 90% (by wt.) binder.
17. The intracorporeal marker of claim 12 , wherein the bioabsorbable body is a press-formed body formed of a mixed powder of polysaccharide and binder.
18. The intracorporeal marker of claim 17 , wherein the binder is selected from a group consisting of methylcellulose, hydroxyethyl cellulose, polyethylene glycol, polyvinyl alcohol, polyvinylpyrolidone.
19. The intracorporeal marker of claim 17 , wherein the binder comprises methylcellulose.
20. The intracorporeal marker of claim 17 , wherein the powder has a particle size less than 0.01 inch, the press-formed body having a length of about 0.1 to about 0.4 inch, and the press-formed body having a transverse dimension of about 0.02 to about 0.1 inch.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/301,297 US20120078092A1 (en) | 1999-02-02 | 2011-11-21 | Remotely imageable marker system and polysaccharide marker for use in same |
Applications Claiming Priority (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/241,936 US6161034A (en) | 1999-02-02 | 1999-02-02 | Methods and chemical preparations for time-limited marking of biopsy sites |
US09/343,975 US6347241B2 (en) | 1999-02-02 | 1999-06-30 | Ultrasonic and x-ray detectable biopsy site marker and apparatus for applying it |
US09/717,909 US6725083B1 (en) | 1999-02-02 | 2000-11-20 | Tissue site markers for in VIVO imaging |
US10/124,757 US6862470B2 (en) | 1999-02-02 | 2002-04-16 | Cavity-filling biopsy site markers |
US10/174,401 US7651505B2 (en) | 2002-06-17 | 2002-06-17 | Plugged tip delivery for marker placement |
US10/374,915 US7189206B2 (en) | 2003-02-24 | 2003-02-24 | Biopsy device with inner cutter |
US10/444,770 US7983734B2 (en) | 2003-05-23 | 2003-05-23 | Fibrous marker and intracorporeal delivery thereof |
US10/642,406 US7819819B2 (en) | 2003-02-24 | 2003-08-15 | Biopsy device with inner cutting member |
US10/753,694 US20040236213A1 (en) | 2003-05-23 | 2004-01-07 | Marker delivery device with releasable plug |
US10/911,106 US8282573B2 (en) | 2003-02-24 | 2004-08-03 | Biopsy device with selectable tissue receiving aperture orientation and site illumination |
US10/990,327 US7792569B2 (en) | 1999-02-02 | 2004-11-16 | Cavity-filling biopsy site markers |
US83574006P | 2006-08-04 | 2006-08-04 | |
US11/881,264 US20080039819A1 (en) | 2006-08-04 | 2007-07-26 | Marker formed of starch or other suitable polysaccharide |
US12/070,786 US20090030309A1 (en) | 2007-07-26 | 2008-02-21 | Deployment of polysaccharide markers |
US12/070,787 US20090216118A1 (en) | 2007-07-26 | 2008-02-21 | Polysaccharide markers |
US12/592,020 US8177792B2 (en) | 2002-06-17 | 2009-11-18 | Plugged tip delivery tube for marker placement |
US12/852,286 US8219182B2 (en) | 1999-02-02 | 2010-08-06 | Cavity-filling biopsy site markers |
US13/037,971 US8361082B2 (en) | 1999-02-02 | 2011-03-01 | Marker delivery device with releasable plug |
US13/155,628 US8626269B2 (en) | 2003-05-23 | 2011-06-08 | Fibrous marker and intracorporeal delivery thereof |
US13/301,297 US20120078092A1 (en) | 1999-02-02 | 2011-11-21 | Remotely imageable marker system and polysaccharide marker for use in same |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/070,787 Continuation-In-Part US20090216118A1 (en) | 1999-02-02 | 2008-02-21 | Polysaccharide markers |
Publications (1)
Publication Number | Publication Date |
---|---|
US20120078092A1 true US20120078092A1 (en) | 2012-03-29 |
Family
ID=47427197
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/070,787 Abandoned US20090216118A1 (en) | 1999-02-02 | 2008-02-21 | Polysaccharide markers |
US12/070,786 Abandoned US20090030309A1 (en) | 1999-02-02 | 2008-02-21 | Deployment of polysaccharide markers |
US13/301,297 Abandoned US20120078092A1 (en) | 1999-02-02 | 2011-11-21 | Remotely imageable marker system and polysaccharide marker for use in same |
US13/301,024 Expired - Fee Related US9149341B2 (en) | 1999-02-02 | 2011-11-21 | Deployment of polysaccharide markers for treating a site within a patient |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/070,787 Abandoned US20090216118A1 (en) | 1999-02-02 | 2008-02-21 | Polysaccharide markers |
US12/070,786 Abandoned US20090030309A1 (en) | 1999-02-02 | 2008-02-21 | Deployment of polysaccharide markers |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/301,024 Expired - Fee Related US9149341B2 (en) | 1999-02-02 | 2011-11-21 | Deployment of polysaccharide markers for treating a site within a patient |
Country Status (7)
Country | Link |
---|---|
US (4) | US20090216118A1 (en) |
EP (1) | EP2244653A1 (en) |
JP (1) | JP2011516408A (en) |
CN (1) | CN101977561A (en) |
AU (1) | AU2009215896B2 (en) |
CA (1) | CA2715743A1 (en) |
WO (1) | WO2009105177A1 (en) |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050189192A1 (en) * | 2002-09-12 | 2005-09-01 | Luk Lamellen Und Kupplungsbau Beteiligungs Kg | Method for reducing juddering vibrations |
US8626269B2 (en) | 2003-05-23 | 2014-01-07 | Senorx, Inc. | Fibrous marker and intracorporeal delivery thereof |
US8626270B2 (en) | 1999-02-02 | 2014-01-07 | Senorx, Inc. | Cavity-filling biopsy site markers |
US8634899B2 (en) | 2003-11-17 | 2014-01-21 | Bard Peripheral Vascular, Inc. | Multi mode imaging marker |
US8639315B2 (en) | 2003-05-23 | 2014-01-28 | Senorx, Inc. | Marker or filler forming fluid |
US8668737B2 (en) | 1997-10-10 | 2014-03-11 | Senorx, Inc. | Tissue marking implant |
US8718745B2 (en) | 2000-11-20 | 2014-05-06 | Senorx, Inc. | Tissue site markers for in vivo imaging |
US8784433B2 (en) | 2002-06-17 | 2014-07-22 | Senorx, Inc. | Plugged tip delivery tube for marker placement |
USD715442S1 (en) | 2013-09-24 | 2014-10-14 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD715942S1 (en) | 2013-09-24 | 2014-10-21 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD716451S1 (en) | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD716450S1 (en) | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
US9042965B2 (en) | 2006-12-18 | 2015-05-26 | C. R. Bard, Inc. | Biopsy marker with in situ-generated imaging properties |
US9044162B2 (en) | 1999-02-02 | 2015-06-02 | Senorx, Inc. | Marker delivery device with releasable plug |
US9149341B2 (en) | 1999-02-02 | 2015-10-06 | Senorx, Inc | Deployment of polysaccharide markers for treating a site within a patient |
US9579159B2 (en) | 1999-06-17 | 2017-02-28 | Bard Peripheral Vascular, Inc. | Apparatus for the percutaneous marking of a lesion |
US9579077B2 (en) | 2006-12-12 | 2017-02-28 | C.R. Bard, Inc. | Multiple imaging mode tissue marker |
US9848956B2 (en) | 2002-11-18 | 2017-12-26 | Bard Peripheral Vascular, Inc. | Self-contained, self-piercing, side-expelling marking apparatus |
US10172674B2 (en) | 1999-02-02 | 2019-01-08 | Senorx, Inc. | Intracorporeal marker and marker delivery device |
US10258428B2 (en) | 2008-12-30 | 2019-04-16 | C. R. Bard, Inc. | Marker delivery device for tissue marker placement |
US10342635B2 (en) | 2005-04-20 | 2019-07-09 | Bard Peripheral Vascular, Inc. | Marking device with retractable cannula |
US10683119B2 (en) | 2014-05-23 | 2020-06-16 | Merit Medical Systems, Inc. | Marker element, device for making a marker element, and method for making a marker element |
US10786604B2 (en) | 2008-09-23 | 2020-09-29 | Senorx, Inc. | Porous bioabsorbable implant |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9820824B2 (en) | 1999-02-02 | 2017-11-21 | Senorx, Inc. | Deployment of polysaccharide markers for treating a site within a patent |
GB0120645D0 (en) | 2001-08-24 | 2001-10-17 | Smiths Group Plc | Medico-surgical devices |
EP1545316B1 (en) * | 2002-08-01 | 2008-01-09 | James E. Selis | Biopsy devices |
GB0307350D0 (en) | 2003-03-29 | 2003-05-07 | Smiths Group Plc | Catheters |
US8075568B2 (en) | 2004-06-11 | 2011-12-13 | Selis James E | Biopsy devices and methods |
US8052658B2 (en) | 2005-10-07 | 2011-11-08 | Bard Peripheral Vascular, Inc. | Drug-eluting tissue marker |
EP2079385B1 (en) | 2006-10-23 | 2013-11-20 | C.R.Bard, Inc. | Breast marker |
US8137320B2 (en) | 2007-05-01 | 2012-03-20 | Suros Surgical Systems, Inc. | Securement for a surgical site marker and deployment device for same |
US8311610B2 (en) | 2008-01-31 | 2012-11-13 | C. R. Bard, Inc. | Biopsy tissue marker |
US9014787B2 (en) | 2009-06-01 | 2015-04-21 | Focal Therapeutics, Inc. | Bioabsorbable target for diagnostic or therapeutic procedure |
JP2012055549A (en) * | 2010-09-10 | 2012-03-22 | Fujifilm Corp | Phantom for biopsy |
US20130289389A1 (en) | 2012-04-26 | 2013-10-31 | Focal Therapeutics | Surgical implant for marking soft tissue |
US20140171385A1 (en) * | 2012-12-14 | 2014-06-19 | Ecd Medical | Materials for Short-Term Use in Mammals |
AU2014207290B2 (en) * | 2013-01-18 | 2018-04-05 | The Johns Hopkins University | Ultrasound-detectable markers, ultrasound system, and methods for monitoring vascular flow and patency |
US9744034B2 (en) | 2013-03-12 | 2017-08-29 | St. Jude Medical, Cardiology Division, Inc. | Radiopaque transcatheter valve and anatomical markers |
US9615915B2 (en) | 2014-07-25 | 2017-04-11 | Focal Therapeutics, Inc. | Implantable devices and techniques for oncoplastic surgery |
EP3203925B1 (en) * | 2014-10-08 | 2024-03-13 | Devicor Medical Products, Inc. | Biopsy marker |
US11116599B2 (en) | 2017-04-07 | 2021-09-14 | View Point Medical, Inc. | Multi-mode imaging markers |
KR20210130756A (en) * | 2019-02-15 | 2021-11-01 | 씨. 알. 바드, 인크. | hemostatic biopsy tube supplies |
EP4021306A4 (en) | 2019-08-28 | 2023-08-23 | View Point Medical, Inc. | Ultrasound marker detection, markers and associated systems, methods and articles |
US11903767B2 (en) | 2019-11-27 | 2024-02-20 | View Point Medical, Inc. | Composite tissue markers detectable via multiple detection modalities |
US11882992B2 (en) | 2019-11-27 | 2024-01-30 | View Point Medical, Inc. | Composite tissue markers detectable via multiple detection modalities including radiopaque element |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2899362A (en) * | 1959-08-11 | Hemostatic sponges and method of | ||
US3005457A (en) * | 1957-04-01 | 1961-10-24 | Ortho Pharma Corp | Methyl cellulose sponge and method of making |
US4950234A (en) * | 1987-05-26 | 1990-08-21 | Sumitomo Pharmaceuticals Company, Limited | Device for administering solid preparations |
US5035891A (en) * | 1987-10-05 | 1991-07-30 | Syntex (U.S.A.) Inc. | Controlled release subcutaneous implant |
US5281197A (en) * | 1992-07-27 | 1994-01-25 | Symbiosis Corporation | Endoscopic hemostatic agent delivery system |
US5405402A (en) * | 1993-04-14 | 1995-04-11 | Intermedics Orthopedics, Inc. | Implantable prosthesis with radiographic marker |
US6228055B1 (en) * | 1994-09-16 | 2001-05-08 | Ethicon Endo-Surgery, Inc. | Devices for marking and defining particular locations in body tissue |
US6288055B1 (en) * | 1998-06-08 | 2001-09-11 | Advanced Medicine, Inc. | Analgesic agents |
US6350274B1 (en) * | 1992-05-11 | 2002-02-26 | Regen Biologics, Inc. | Soft tissue closure systems |
US20020188195A1 (en) * | 2001-06-07 | 2002-12-12 | Mills Stanley L. | Echogenic medical device |
US6554760B2 (en) * | 2000-10-25 | 2003-04-29 | Gary A. Lamoureux | Pre-loaded needle assembly |
US20040265371A1 (en) * | 2003-06-25 | 2004-12-30 | Looney Dwayne Lee | Hemostatic devices and methods of making same |
Family Cites Families (514)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2192270A (en) * | 1938-05-25 | 1940-03-05 | American Brake Co | Brake rigging |
US2481408A (en) | 1946-08-13 | 1949-09-06 | Olin Mathieson | Regeneration of caustic soda-sodium sulfide cooking liquor |
GB708148A (en) | 1950-12-18 | 1954-04-28 | Hoechst Ag | Hemostatic preparations and process for the manufacture thereof |
DE1029528B (en) | 1954-01-30 | 1958-05-08 | Med H C Ernst Pohl Dr | Device for marking a drill hole to be made, especially for bone nails and bone screws |
US2832888A (en) | 1956-05-17 | 1958-04-29 | David R Houston | Box car detector |
US2907327A (en) | 1957-02-08 | 1959-10-06 | Pfizer & Co C | Pellet implanter |
US3128744A (en) | 1963-01-02 | 1964-04-14 | Keith B Jefferts | Method for investigating the migratory habits of macro-organisms |
US3341417A (en) | 1965-07-14 | 1967-09-12 | Edwin S Sinaiko | Method of and means for diagnosis of ingested drugs with radio-opaque and other indicators |
US3516412A (en) | 1965-08-16 | 1970-06-23 | Electro Catheter Corp | Bipolar electrode having irregularity at inserting end thereof and method of insertion |
US3402712A (en) | 1966-07-19 | 1968-09-24 | American Home Prod | Pellet implanter |
US3593343A (en) * | 1968-07-19 | 1971-07-20 | Robert F Viggers | Prosthetic ball-check heart valve |
US3823212A (en) * | 1968-11-27 | 1974-07-09 | Freudenberg C Fa | Process for the production of collagen fiber fabrics in the form of felt-like membranes or sponge-like layers |
CS151338B1 (en) * | 1971-01-22 | 1973-10-19 | ||
US3757781A (en) | 1971-09-17 | 1973-09-11 | R Smart | Tool for administering pills to animals |
US3820545A (en) | 1973-03-26 | 1974-06-28 | K Jefferts | Tag implanting machine |
US3921632A (en) | 1974-08-16 | 1975-11-25 | Frank M Bardani | Implant device |
US4197846A (en) * | 1974-10-09 | 1980-04-15 | Louis Bucalo | Method for structure for situating in a living body agents for treating the body |
US4005699A (en) | 1974-10-09 | 1977-02-01 | Louis Bucalo | Methods and apparatus for use in magnetic treatment of the body |
US4007732A (en) * | 1975-09-02 | 1977-02-15 | Robert Carl Kvavle | Method for location and removal of soft tissue in human biopsy operations |
US4041931A (en) | 1976-05-17 | 1977-08-16 | Elliott Donald P | Radiopaque anastomosis marker |
US4217889A (en) | 1976-09-15 | 1980-08-19 | Heyer-Schulte Corporation | Flap development device and method of progressively increasing skin area |
US4105030A (en) | 1977-01-03 | 1978-08-08 | Syntex (U.S.A.) Inc. | Implant apparatus |
US4086914A (en) | 1977-02-11 | 1978-05-02 | Edwin Bailey Moore | Implant injector |
US4103690A (en) | 1977-03-21 | 1978-08-01 | Cordis Corporation | Self-suturing cardiac pacer lead |
US4294241A (en) | 1977-06-09 | 1981-10-13 | Teruo Miyata | Collagen skin dressing |
US4127774A (en) | 1977-06-20 | 1978-11-28 | Jerry Gillen | X-ray marker |
DE2843963A1 (en) | 1978-10-09 | 1980-04-24 | Merck Patent Gmbh | BODY-RESORBABLE SHAPED MATERIAL BASED ON COLLAGEN AND THEIR USE IN MEDICINE |
US4588395A (en) | 1978-03-10 | 1986-05-13 | Lemelson Jerome H | Catheter and method |
US4172449A (en) | 1978-05-01 | 1979-10-30 | New Research And Development Laboratories, Inc. | Body fluid pressure monitor |
US4276885A (en) * | 1979-05-04 | 1981-07-07 | Rasor Associates, Inc | Ultrasonic image enhancement |
US4331654A (en) * | 1980-06-13 | 1982-05-25 | Eli Lilly And Company | Magnetically-localizable, biodegradable lipid microspheres |
US4390018A (en) * | 1980-09-15 | 1983-06-28 | Zukowski Henry J | Method for preventing loss of spinal fluid after spinal tap |
US4442843A (en) | 1980-11-17 | 1984-04-17 | Schering, Ag | Microbubble precursors and methods for their production and use |
US4740208A (en) | 1980-11-21 | 1988-04-26 | Cavon Joseph F | Cast gel implantable prosthesis |
US4470160A (en) | 1980-11-21 | 1984-09-11 | Cavon Joseph F | Cast gel implantable prosthesis |
US4428082A (en) | 1980-12-08 | 1984-01-31 | Naficy Sadeque S | Breast prosthesis with filling valve |
US4298998A (en) | 1980-12-08 | 1981-11-10 | Naficy Sadeque S | Breast prosthesis with biologically absorbable outer container |
US4487209A (en) | 1981-03-16 | 1984-12-11 | Creative Research And Manufacturing Inc. | Biopsy needle |
US4401124A (en) | 1981-08-13 | 1983-08-30 | Technicare Corporation | Reflection enhancement of a biopsy needle |
US4400170A (en) | 1981-09-29 | 1983-08-23 | Syntex (U.S.A.) Inc. | Implanting device and implant magazine |
US4582061A (en) | 1981-11-18 | 1986-04-15 | Indianapolis Center For Advanced Research, Inc. | Needle with ultrasonically reflective displacement scale |
US4582640A (en) | 1982-03-08 | 1986-04-15 | Collagen Corporation | Injectable cross-linked collagen implant material |
US4405314A (en) | 1982-04-19 | 1983-09-20 | Cook Incorporated | Apparatus and method for catheterization permitting use of a smaller gage needle |
US4545367A (en) | 1982-07-16 | 1985-10-08 | Cordis Corporation | Detachable balloon catheter and method of use |
US5542915A (en) | 1992-08-12 | 1996-08-06 | Vidamed, Inc. | Thermal mapping catheter with ultrasound probe |
US4438253A (en) | 1982-11-12 | 1984-03-20 | American Cyanamid Company | Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same |
GB2138298B (en) | 1983-04-21 | 1986-11-05 | Hundon Forge Ltd | Pellet implanter |
US4647480A (en) * | 1983-07-25 | 1987-03-03 | Amchem Products, Inc. | Use of additive in aqueous cure of autodeposited coatings |
US4655226A (en) | 1983-12-16 | 1987-04-07 | Southland Instruments, Inc. | Disposable biopsy needle unit |
CH661199A5 (en) | 1983-12-22 | 1987-07-15 | Sulzer Ag | MARKING IMPLANT. |
US4549560A (en) | 1984-03-19 | 1985-10-29 | Andis Company | Hair curling appliance with elastomer material covering heating element |
IL74715A0 (en) | 1984-03-27 | 1985-06-30 | Univ New Jersey Med | Biodegradable matrix and methods for producing same |
US4963150B1 (en) | 1984-08-30 | 1994-10-04 | Daniel Brauman | Implantable prosthetic device |
US4648880A (en) | 1984-08-30 | 1987-03-10 | Daniel Brauman | Implantable prosthetic devices |
US4820267A (en) | 1985-02-19 | 1989-04-11 | Endocon, Inc. | Cartridge injector for pellet medicaments |
US4863470A (en) | 1985-03-19 | 1989-09-05 | Medical Engineering Corporation | Identification marker for a breast prosthesis |
US5628781A (en) | 1985-06-06 | 1997-05-13 | Thomas Jefferson University | Implant materials, methods of treating the surface of implants with microvascular endothelial cells, and the treated implants themselves |
US4847049A (en) * | 1985-12-18 | 1989-07-11 | Vitaphore Corporation | Method of forming chelated collagen having bactericidal properties |
US4693237A (en) | 1986-01-21 | 1987-09-15 | Hoffman Richard B | Radiopaque coded ring markers for use in identifying surgical grafts |
US4682606A (en) | 1986-02-03 | 1987-07-28 | Decaprio Vincent H | Localizing biopsy apparatus |
US4661103A (en) | 1986-03-03 | 1987-04-28 | Engineering Development Associates, Ltd. | Multiple implant injector |
US4832686A (en) * | 1986-06-24 | 1989-05-23 | Anderson Mark E | Method for administering interleukin-2 |
US4832680A (en) | 1986-07-03 | 1989-05-23 | C.R. Bard, Inc. | Apparatus for hypodermically implanting a genitourinary prosthesis |
ES2053019T3 (en) | 1986-07-30 | 1994-07-16 | Sumitomo Pharma | SOLID PREPARATION ADMINISTRATION INSTRUMENT. |
US4813062A (en) * | 1986-08-13 | 1989-03-14 | Milliken Research Corporation | Radio-opaque marker and method |
US4762128A (en) | 1986-12-09 | 1988-08-09 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating hypertrophy of the prostate gland |
US4994028A (en) | 1987-03-18 | 1991-02-19 | Endocon, Inc. | Injector for inplanting multiple pellet medicaments |
US4874376A (en) | 1987-04-13 | 1989-10-17 | Hawkins Jr Irvin F | Needle guide assembly |
US4989608A (en) | 1987-07-02 | 1991-02-05 | Ratner Adam V | Device construction and method facilitating magnetic resonance imaging of foreign objects in a body |
US5120802A (en) | 1987-12-17 | 1992-06-09 | Allied-Signal Inc. | Polycarbonate-based block copolymers and devices |
US4889707A (en) | 1988-01-29 | 1989-12-26 | The Curators Of The University Of Missouri | Composition and method for radiation synovectomy of arthritic joints |
US4870966A (en) | 1988-02-01 | 1989-10-03 | American Cyanamid Company | Bioabsorbable surgical device for treating nerve defects |
US5425366A (en) * | 1988-02-05 | 1995-06-20 | Schering Aktiengesellschaft | Ultrasonic contrast agents for color Doppler imaging |
EP0327490A1 (en) * | 1988-02-05 | 1989-08-09 | Schering Aktiengesellschaft | Ultrasonic imaging agents, process for their preparation and their diagnostic and therapeutical use |
US5374261A (en) | 1990-07-24 | 1994-12-20 | Yoon; Inbae | Multifunctional devices for use in endoscopic surgical procedures and methods-therefor |
US4994013A (en) | 1988-07-28 | 1991-02-19 | Best Industries, Inc. | Pellet for a radioactive seed |
US5702716A (en) | 1988-10-03 | 1997-12-30 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
US4938763B1 (en) * | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
US4950665A (en) | 1988-10-28 | 1990-08-21 | Oklahoma Medical Research Foundation | Phototherapy using methylene blue |
US4909250A (en) * | 1988-11-14 | 1990-03-20 | Smith Joseph R | Implant system for animal identification |
US5800541A (en) | 1988-11-21 | 1998-09-01 | Collagen Corporation | Collagen-synthetic polymer matrices prepared using a multiple step reaction |
US5162430A (en) | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
US5475052A (en) | 1988-11-21 | 1995-12-12 | Collagen Corporation | Collagen-synthetic polymer matrices prepared using a multiple step reaction |
WO1990009152A1 (en) | 1989-02-15 | 1990-08-23 | Microtek Medical, Inc. | Biocompatible material and prosthesis |
US5141748A (en) | 1989-02-17 | 1992-08-25 | Hoffmann-La Roche, Inc. | Implant drug delivery device |
US5081997A (en) | 1989-03-09 | 1992-01-21 | Vance Products Incorporated | Echogenic devices, material and method |
US5289831A (en) * | 1989-03-09 | 1994-03-01 | Vance Products Incorporated | Surface-treated stent, catheter, cannula, and the like |
US5201314A (en) | 1989-03-09 | 1993-04-13 | Vance Products Incorporated | Echogenic devices, material and method |
US5025797A (en) | 1989-03-29 | 1991-06-25 | Baran Gregory W | Automated biopsy instrument |
GB2230191B (en) | 1989-04-15 | 1992-04-22 | Robert Graham Urie | Lesion location device |
DE8905585U1 (en) | 1989-05-03 | 1989-06-29 | Bosch-Siemens Hausgeraete Gmbh, 8000 Muenchen, De | |
US5012818A (en) | 1989-05-04 | 1991-05-07 | Joishy Suresh K | Two in one bone marrow surgical needle |
US5234426A (en) | 1989-06-15 | 1993-08-10 | Research Corporation Technologies, Inc. | Helical-tipped lesion localization needle device and method of using the same |
US5197482A (en) | 1989-06-15 | 1993-03-30 | Research Corporation Technologies, Inc. | Helical-tipped lesion localization needle device and method of using the same |
US5018530A (en) | 1989-06-15 | 1991-05-28 | Research Corporation Technologies, Inc. | Helical-tipped lesion localization needle device and method of using the same |
US5284479A (en) | 1989-08-30 | 1994-02-08 | N.V. Nederlandsche Apparatenfabriek Nedap | Implanter |
US5271961A (en) | 1989-11-06 | 1993-12-21 | Alkermes Controlled Therapeutics, Inc. | Method for producing protein microspheres |
US5201704A (en) | 1989-11-07 | 1993-04-13 | Ray Joel W | Method of making and using a hemostatic agent applicator |
JPH03158171A (en) | 1989-11-17 | 1991-07-08 | Masataka Saito | Cap integral type disposal injection needle |
US5197846A (en) | 1989-12-22 | 1993-03-30 | Hitachi, Ltd. | Six-degree-of-freedom articulated robot mechanism and assembling and working apparatus using same |
US5334381A (en) | 1989-12-22 | 1994-08-02 | Unger Evan C | Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
US5585112A (en) | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
GB9003821D0 (en) | 1990-02-20 | 1990-04-18 | Danbiosyst Uk | Diagnostic aid |
JPH042372U (en) | 1990-04-23 | 1992-01-09 | ||
US5137928A (en) | 1990-04-26 | 1992-08-11 | Hoechst Aktiengesellschaft | Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents |
AU636481B2 (en) | 1990-05-18 | 1993-04-29 | Bracco International B.V. | Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography |
US5236410A (en) | 1990-08-02 | 1993-08-17 | Ferrotherm International, Inc. | Tumor treatment method |
DE69120177T2 (en) | 1990-09-10 | 1996-10-10 | Synthes Ag | Bone regeneration membrane |
US5353804A (en) | 1990-09-18 | 1994-10-11 | Peb Biopsy Corporation | Method and device for percutaneous exisional breast biopsy |
US5391183A (en) | 1990-09-21 | 1995-02-21 | Datascope Investment Corp | Device and method sealing puncture wounds |
US5221269A (en) | 1990-10-15 | 1993-06-22 | Cook Incorporated | Guide for localizing a nonpalpable breast lesion |
US6347240B1 (en) | 1990-10-19 | 2002-02-12 | St. Louis University | System and method for use in displaying images of a body part |
US5282781A (en) * | 1990-10-25 | 1994-02-01 | Omnitron International Inc. | Source wire for localized radiation treatment of tumors |
US6325789B1 (en) | 1990-12-27 | 2001-12-04 | Datascope Investment Corporation | Device and method for sealing puncture wounds |
US5370901A (en) | 1991-02-15 | 1994-12-06 | Bracco International B.V. | Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients |
US5280788A (en) | 1991-02-26 | 1994-01-25 | Massachusetts Institute Of Technology | Devices and methods for optical diagnosis of tissue |
EP0574434B1 (en) * | 1991-03-06 | 1995-07-26 | Süddeutsche Feinmechanik Gmbh | Needle for inserting an object into the body |
JP3007903B2 (en) | 1991-03-29 | 2000-02-14 | 京セラ株式会社 | Artificial disc |
US5205290A (en) * | 1991-04-05 | 1993-04-27 | Unger Evan C | Low density microspheres and their use as contrast agents for computed tomography |
US5147631A (en) | 1991-04-30 | 1992-09-15 | Du Pont Merck Pharmaceutical Company | Porous inorganic ultrasound contrast agents |
US5354623A (en) | 1991-05-21 | 1994-10-11 | Cook Incorporated | Joint, a laminate, and a method of preparing a nickel-titanium alloy member surface for bonding to another layer of metal |
US5242759A (en) | 1991-05-21 | 1993-09-07 | Cook Incorporated | Joint, a laminate, and a method of preparing a nickel-titanium alloy member surface for bonding to another layer of metal |
US5147307A (en) | 1991-06-17 | 1992-09-15 | Gluck Seymour M | Anatomical marker device and method |
US5449560A (en) | 1991-07-05 | 1995-09-12 | Dow Corning S.A. | Composition suitable for glass laminate interlayer and laminate made therefrom |
JPH06511481A (en) | 1991-07-05 | 1994-12-22 | ユニバーシティ オブ ロチェスター | Ultra-fine non-agglomerated porous particles that incorporate air bubbles |
US5195540A (en) | 1991-08-12 | 1993-03-23 | Samuel Shiber | Lesion marking process |
US5199441A (en) | 1991-08-20 | 1993-04-06 | Hogle Hugh H | Fine needle aspiration biopsy apparatus and method |
NL9101489A (en) | 1991-09-03 | 1993-04-01 | Texas Instruments Holland | INJECTOR FOR IMMEDIATELY IMPLANTING AN OBJECT IN A LIVING BEING. |
US5320100A (en) | 1991-09-16 | 1994-06-14 | Atrium Medical Corporation | Implantable prosthetic device having integral patency diagnostic indicia |
US5344640A (en) | 1991-10-22 | 1994-09-06 | Mallinckrodt Medical, Inc. | Preparation of apatite particles for medical diagnostic imaging |
US5358514A (en) | 1991-12-18 | 1994-10-25 | Alfred E. Mann Foundation For Scientific Research | Implantable microdevice with self-attaching electrodes |
GB9200391D0 (en) | 1992-01-09 | 1992-02-26 | Nycomed As | Improvements in or relating to contrast agents |
FR2686499A1 (en) | 1992-01-28 | 1993-07-30 | Technomed Int Sa | APPARATUS FOR TREATING A TARGET, SUCH AS A DAMAGE WITHIN THE BODY OF A MAMMAL, PARTICULARLY A HUMAN BEING, USING A MARKING ELEMENT IMPLANTED IN OR IN THE VICINITY OF THE TARGET TO CONTROL THERAPY OF THE SAME TARGET. |
CA2131032A1 (en) * | 1992-02-28 | 1993-09-02 | Stanley E. Order | Use of aggregated proteins to prolong retention time of a therapeutic agent adjacent a targeted site such as a tumor |
CA2131024A1 (en) | 1992-03-06 | 1993-09-16 | Arsalan Kharazmi | Treatment and prophylaxis of diseases caused by parasites, or bacteria |
LV10396B (en) | 1992-03-06 | 1996-02-20 | Nycomed Imaging As | Novel contrast agents |
US5674468A (en) | 1992-03-06 | 1997-10-07 | Nycomed Imaging As | Contrast agents comprising gas-containing or gas-generating polymer microparticles or microballoons |
NL9200844A (en) | 1992-05-13 | 1993-12-01 | De Wijdeven Gijsbertus G P Van | DEVICE AND METHOD FOR INJECTING WITH A SOLID SUBSTANCE. |
US5250026A (en) | 1992-05-27 | 1993-10-05 | Destron/Idi, Inc. | Adjustable precision transponder injector |
US5629008A (en) * | 1992-06-02 | 1997-05-13 | C.R. Bard, Inc. | Method and device for long-term delivery of drugs |
US5366756A (en) | 1992-06-15 | 1994-11-22 | United States Surgical Corporation | Method for treating bioabsorbable implant material |
US5368030A (en) | 1992-09-09 | 1994-11-29 | Izi Corporation | Non-invasive multi-modality radiographic surface markers |
US5469847A (en) | 1992-09-09 | 1995-11-28 | Izi Corporation | Radiographic multi-modality skin markers |
US5460182A (en) | 1992-09-14 | 1995-10-24 | Sextant Medical Corporation | Tissue penetrating apparatus and methods |
US5334216A (en) | 1992-12-10 | 1994-08-02 | Howmedica Inc. | Hemostatic plug |
US5320613A (en) * | 1993-01-06 | 1994-06-14 | Scimed Life Systems, Inc. | Medical lumen flushing and guide wire loading device and method |
EP0636015A4 (en) | 1993-01-19 | 1995-08-02 | Hang Fu Lee | Apparatus and method for implant prostheses. |
DK12293D0 (en) * | 1993-02-02 | 1993-02-02 | Novo Nordisk As | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE |
US5799099A (en) | 1993-02-12 | 1998-08-25 | George S. Allen | Automatic technique for localizing externally attached fiducial markers in volume images of the head |
US5551429A (en) | 1993-02-12 | 1996-09-03 | Fitzpatrick; J. Michael | Method for relating the data of an image space to physical space |
US5362478A (en) * | 1993-03-26 | 1994-11-08 | Vivorx Pharmaceuticals, Inc. | Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell |
DE4306277C2 (en) | 1993-03-01 | 2000-11-02 | Leibinger Gmbh | Operation marking tool |
US5388588A (en) | 1993-05-04 | 1995-02-14 | Nabai; Hossein | Biopsy wound closure device and method |
US5312435A (en) | 1993-05-17 | 1994-05-17 | Kensey Nash Corporation | Fail predictable, reinforced anchor for hemostatic puncture closure |
US5409004A (en) | 1993-06-11 | 1995-04-25 | Cook Incorporated | Localization device with radiopaque markings |
US5886026A (en) | 1993-07-19 | 1999-03-23 | Angiotech Pharmaceuticals Inc. | Anti-angiogenic compositions and methods of use |
US5494030A (en) * | 1993-08-12 | 1996-02-27 | Trustees Of Dartmouth College | Apparatus and methodology for determining oxygen in biological systems |
US5431639A (en) | 1993-08-12 | 1995-07-11 | Boston Scientific Corporation | Treating wounds caused by medical procedures |
US5490521A (en) | 1993-08-31 | 1996-02-13 | Medtronic, Inc. | Ultrasound biopsy needle |
US5676698A (en) | 1993-09-07 | 1997-10-14 | Datascope Investment Corp. | Soft tissue implant |
US5394875A (en) * | 1993-10-21 | 1995-03-07 | Lewis; Judith T. | Automatic ultrasonic localization of targets implanted in a portion of the anatomy |
US5433204A (en) * | 1993-11-16 | 1995-07-18 | Camilla Olson | Method of assessing placentation |
US5545180A (en) | 1993-12-13 | 1996-08-13 | Ethicon, Inc. | Umbrella-shaped suture anchor device with actuating ring member |
US5728122A (en) | 1994-01-18 | 1998-03-17 | Datascope Investment Corp. | Guide wire with releaseable barb anchor |
US6241734B1 (en) | 1998-08-14 | 2001-06-05 | Kyphon, Inc. | Systems and methods for placing materials into bone |
US5626611A (en) | 1994-02-10 | 1997-05-06 | United States Surgical Corporation | Composite bioabsorbable materials and surgical articles made therefrom |
US5928773A (en) | 1994-02-15 | 1999-07-27 | Vitric Corporation | Foamed glass articles and methods of making same and methods of controlling the pH of same within specific limits |
US5507807A (en) | 1994-03-01 | 1996-04-16 | Shippert; Ronald D. | Apparatus for the release of a substance within a patient |
US5417708A (en) | 1994-03-09 | 1995-05-23 | Cook Incorporated | Intravascular treatment system and percutaneous release mechanism therefor |
US5422730A (en) * | 1994-03-25 | 1995-06-06 | Barlow; Clyde H. | Automated optical detection of tissue perfusion by microspheres |
US5451406A (en) | 1994-07-14 | 1995-09-19 | Advanced Uroscience, Inc. | Tissue injectable composition and method of use |
US6159445A (en) | 1994-07-20 | 2000-12-12 | Nycomed Imaging As | Light imaging contrast agents |
US5954670A (en) | 1994-10-05 | 1999-09-21 | Baker; Gary H. | Mandrel-guided tandem multiple channel biopsy guide device and method of use |
US5891558A (en) | 1994-11-22 | 1999-04-06 | Tissue Engineering, Inc. | Biopolymer foams for use in tissue repair and reconstruction |
US5632432A (en) | 1994-12-19 | 1997-05-27 | Ethicon Endo-Surgery, Inc. | Surgical instrument |
US5499989A (en) | 1994-12-22 | 1996-03-19 | Labash; Stephen S. | Breast biopsy apparatus and method of use |
US6540981B2 (en) * | 1997-12-04 | 2003-04-01 | Amersham Health As | Light imaging contrast agents |
US5657366A (en) | 1995-02-23 | 1997-08-12 | Nakayama; Masanari | Film markers for specifying body postures of animal photographed in roentgenograms |
US5643246A (en) * | 1995-02-24 | 1997-07-01 | Gel Sciences, Inc. | Electromagnetically triggered, responsive gel based drug delivery device |
FR2731343B1 (en) | 1995-03-08 | 1997-08-22 | De La Joliniere Jean H Bouquet | DEVICE FOR LOCATING SUSPECTED BREAST INJURIES AND APPARATUS FOR PLACING SAME |
US5795308A (en) | 1995-03-09 | 1998-08-18 | Russin; Lincoln D. | Apparatus for coaxial breast biopsy |
US5762903A (en) * | 1995-03-10 | 1998-06-09 | Korea Atomic Energy Research Institute | Radioactive chitosan complex for radiation therapy |
US5817022A (en) | 1995-03-28 | 1998-10-06 | Sonometrics Corporation | System for displaying a 2-D ultrasound image within a 3-D viewing environment |
US5782771A (en) | 1995-04-17 | 1998-07-21 | Hussman; Karl L. | Dual, fused, and grooved optical localization fibers |
US6135993A (en) | 1995-04-17 | 2000-10-24 | Hussman; Karl L. | Optical localization fiber |
US6120536A (en) | 1995-04-19 | 2000-09-19 | Schneider (Usa) Inc. | Medical devices with long term non-thrombogenic coatings |
GB2301362B (en) | 1995-05-30 | 1999-01-06 | Johnson & Johnson Medical | Absorbable implant materials having controlled porosity |
US5779647A (en) | 1995-06-07 | 1998-07-14 | Chau; Sonny | Automated biopsy instruments |
US5609629A (en) | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
US6521211B1 (en) | 1995-06-07 | 2003-02-18 | Bristol-Myers Squibb Medical Imaging, Inc. | Methods of imaging and treatment with targeted compositions |
US6774278B1 (en) | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
US5580568A (en) | 1995-07-27 | 1996-12-03 | Micro Therapeutics, Inc. | Cellulose diacetate compositions for use in embolizing blood vessels |
US5667767A (en) | 1995-07-27 | 1997-09-16 | Micro Therapeutics, Inc. | Compositions for use in embolizing blood vessels |
US5817034A (en) | 1995-09-08 | 1998-10-06 | United States Surgical Corporation | Apparatus and method for removing tissue |
US5611352A (en) | 1995-09-14 | 1997-03-18 | Kobren; Myles S. | Cervical biopsy device |
US6162192A (en) | 1998-05-01 | 2000-12-19 | Sub Q, Inc. | System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge |
US6071301A (en) * | 1998-05-01 | 2000-06-06 | Sub Q., Inc. | Device and method for facilitating hemostasis of a biopsy tract |
US6183497B1 (en) * | 1998-05-01 | 2001-02-06 | Sub-Q, Inc. | Absorbable sponge with contrasting agent |
DE69633411T2 (en) | 1995-10-13 | 2005-10-20 | Transvascular, Inc., Menlo Park | METHOD AND DEVICE FOR PREVENTING ARTERIAL ATTRACTIONS AND / OR FOR CARRYING OUT OTHER TRANSVASCULAR INTERVENTIONS |
WO1997013471A1 (en) | 1995-10-13 | 1997-04-17 | Transvascular, Inc. | A device, system and method for interstitial transvascular intervention |
US5800445A (en) | 1995-10-20 | 1998-09-01 | United States Surgical Corporation | Tissue tagging device |
CA2187975C (en) | 1995-10-20 | 2001-05-01 | Lisa W. Heaton | Surgical apparatus and method for marking tissue location |
US5782775A (en) * | 1995-10-20 | 1998-07-21 | United States Surgical Corporation | Apparatus and method for localizing and removing tissue |
US5782764A (en) | 1995-11-07 | 1998-07-21 | Iti Medical Technologies, Inc. | Fiber composite invasive medical instruments and methods for use in interventional imaging procedures |
US5702682A (en) | 1995-12-01 | 1997-12-30 | Hercules Incorporated | Methods for preparing radiopaque medical devices |
US5769086A (en) | 1995-12-06 | 1998-06-23 | Biopsys Medical, Inc. | Control system and method for automated biopsy device |
US5752974A (en) | 1995-12-18 | 1998-05-19 | Collagen Corporation | Injectable or implantable biomaterials for filling or blocking lumens and voids of the body |
US6203524B1 (en) | 1997-02-10 | 2001-03-20 | Emx, Inc. | Surgical and pharmaceutical site access guide and methods |
US5800389A (en) | 1996-02-09 | 1998-09-01 | Emx, Inc. | Biopsy device |
US5842477A (en) | 1996-02-21 | 1998-12-01 | Advanced Tissue Sciences, Inc. | Method for repairing cartilage |
US5636255A (en) * | 1996-03-05 | 1997-06-03 | Queen's University At Kingston | Method and apparatus for CT image registration |
JP2000509014A (en) * | 1996-03-11 | 2000-07-18 | フォーカル,インコーポレイテッド | Polymer delivery of radionuclides and radiopharmaceuticals |
US5747060A (en) * | 1996-03-26 | 1998-05-05 | Euro-Celtique, S.A. | Prolonged local anesthesia with colchicine |
US5821184A (en) | 1996-03-29 | 1998-10-13 | Andrew Ungerleider | Foamed glass article for preparing surfaces, use therefor, and method of making same |
US5865806A (en) | 1996-04-04 | 1999-02-02 | Becton Dickinson And Company | One step catheter advancement automatic needle retraction system |
US5824042A (en) | 1996-04-05 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses having position indicating markers |
US5669882A (en) | 1996-04-23 | 1997-09-23 | Pyles; Stephen | Curved epidural needle system |
US7236816B2 (en) | 1996-04-25 | 2007-06-26 | Johns Hopkins University | Biopsy and sampling needle antennas for magnetic resonance imaging-guided biopsies |
US5846220A (en) | 1996-04-30 | 1998-12-08 | Medtronic, Inc. | Therapeutic method for treatment of Alzheimer's disease |
US6530896B1 (en) | 1996-05-13 | 2003-03-11 | James B. Elliott | Apparatus and method for introducing an implant |
US5690120A (en) | 1996-05-24 | 1997-11-25 | Sarcos, Inc. | Hybrid catheter guide wire apparatus |
US5853366A (en) | 1996-07-08 | 1998-12-29 | Kelsey, Inc. | Marker element for interstitial treatment and localizing device and method using same |
US5820918A (en) | 1996-07-11 | 1998-10-13 | Hercules Incorporated | Medical devices containing in-situ generated medical compounds |
US5702128A (en) | 1996-07-18 | 1997-12-30 | Beekley Corporation | Radiographic marker system and method of making same |
US5695480A (en) | 1996-07-29 | 1997-12-09 | Micro Therapeutics, Inc. | Embolizing compositions |
US5830178A (en) | 1996-10-11 | 1998-11-03 | Micro Therapeutics, Inc. | Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide |
US5823198A (en) | 1996-07-31 | 1998-10-20 | Micro Therapeutics, Inc. | Method and apparatus for intravasculer embolization |
US5842999A (en) | 1996-07-31 | 1998-12-01 | C.R. Bard, Inc. | Automated tissue sampling device |
US5902310A (en) | 1996-08-12 | 1999-05-11 | Ethicon Endo-Surgery, Inc. | Apparatus and method for marking tissue |
US6066325A (en) | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
US5676146B1 (en) | 1996-09-13 | 2000-04-18 | Osteotech Inc | Surgical implant containing a resorbable radiopaque marker and method of locating such within a body |
US5824081A (en) | 1996-09-13 | 1998-10-20 | Lipomatrix Incorporated | Hydraulic foam tissue implant |
US6166079A (en) * | 1996-09-25 | 2000-12-26 | Board Of Regents, The University Of Texas System | DFMO for the treatment or prevention of cervical intraepithelial neoplasia |
AU733495B2 (en) | 1996-10-28 | 2001-05-17 | Nycomed Imaging As | Improvements in or relating to diagnostic/therapeutic agents |
US5845646A (en) | 1996-11-05 | 1998-12-08 | Lemelson; Jerome | System and method for treating select tissue in a living being |
US6106473A (en) | 1996-11-06 | 2000-08-22 | Sts Biopolymers, Inc. | Echogenic coatings |
US6119031A (en) | 1996-11-21 | 2000-09-12 | Boston Scientific Corporation | Miniature spectrometer |
US5897507A (en) | 1996-11-25 | 1999-04-27 | Symbiosis Corporation | Biopsy forceps instrument having irrigation and aspiration capabilities |
US5876340A (en) | 1997-04-17 | 1999-03-02 | Irvine Biomedical, Inc. | Ablation apparatus with ultrasonic imaging capabilities |
US5941439A (en) | 1997-05-14 | 1999-08-24 | Mitek Surgical Products, Inc. | Applicator and method for deploying a surgical fastener in tissue |
US5876457A (en) * | 1997-05-20 | 1999-03-02 | George J. Picha | Spinal implant |
JP2002503991A (en) * | 1997-06-13 | 2002-02-05 | マイクロ・テラピューティクス・インコーポレーテッド | Syringe and luer hub having novel shape and method of forming embolus |
GB9712525D0 (en) | 1997-06-16 | 1997-08-20 | Nycomed Imaging As | Method |
US6306154B1 (en) | 1997-06-18 | 2001-10-23 | Bhk Holding | Hemostatic system for body cavities |
US5976146A (en) | 1997-07-11 | 1999-11-02 | Olympus Optical Co., Ltd. | Surgical operation system and method of securing working space for surgical operation in body |
DE19731021A1 (en) | 1997-07-18 | 1999-01-21 | Meyer Joerg | In vivo degradable metallic implant |
US6096037A (en) | 1997-07-29 | 2000-08-01 | Medtronic, Inc. | Tissue sealing electrosurgery device and methods of sealing tissue |
US6096065A (en) | 1997-09-29 | 2000-08-01 | Boston Scientific Corporation | Sheath for tissue spectroscopy |
US5980564A (en) | 1997-08-01 | 1999-11-09 | Schneider (Usa) Inc. | Bioabsorbable implantable endoprosthesis with reservoir |
US6174330B1 (en) | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US6340367B1 (en) | 1997-08-01 | 2002-01-22 | Boston Scientific Scimed, Inc. | Radiopaque markers and methods of using the same |
US6090996A (en) | 1997-08-04 | 2000-07-18 | Collagen Matrix, Inc. | Implant matrix |
EP1003422B1 (en) | 1997-08-05 | 2006-06-14 | Boston Scientific Limited | Detachable aneurysm neck bridge |
US6316522B1 (en) | 1997-08-18 | 2001-11-13 | Scimed Life Systems, Inc. | Bioresorbable hydrogel compositions for implantable prostheses |
US5854382A (en) | 1997-08-18 | 1998-12-29 | Meadox Medicals, Inc. | Bioresorbable compositions for implantable prostheses |
US7125397B2 (en) | 1997-08-20 | 2006-10-24 | B. Braun Melsungen Ag | Protective device for an injection needle |
DE20103363U1 (en) | 2001-02-26 | 2001-05-17 | Braun Melsungen Ag | Protection device for an injection needle |
US6117108A (en) | 1997-08-20 | 2000-09-12 | Braun Melsungen Ag | Spring clip safety IV catheter |
US6616630B1 (en) | 1997-08-20 | 2003-09-09 | B. Braun Melsungen A.G. | Spring clip safety IV catheter |
EP1009317A4 (en) | 1997-08-28 | 2001-01-24 | Boston Scient Corp | System for implanting a cross-linked polysaccharide fiber and methods of forming and inserting the fiber |
US6551253B2 (en) | 1997-09-12 | 2003-04-22 | Imagyn Medical Technologies | Incisional breast biopsy device |
US6142955A (en) | 1997-09-19 | 2000-11-07 | United States Surgical Corporation | Biopsy apparatus and method |
US8668737B2 (en) | 1997-10-10 | 2014-03-11 | Senorx, Inc. | Tissue marking implant |
AU1070899A (en) | 1997-10-10 | 1999-05-03 | Corbitt, John D. Jr. | Breast implant |
US6638308B2 (en) | 1997-10-10 | 2003-10-28 | John D. Corbitt, Jr. | Bioabsorbable breast implant |
US7637948B2 (en) | 1997-10-10 | 2009-12-29 | Senorx, Inc. | Tissue marking implant |
US6309420B1 (en) * | 1997-10-14 | 2001-10-30 | Parallax Medical, Inc. | Enhanced visibility materials for implantation in hard tissue |
US6511468B1 (en) * | 1997-10-17 | 2003-01-28 | Micro Therapeutics, Inc. | Device and method for controlling injection of liquid embolic composition |
AU1114699A (en) | 1997-10-24 | 1999-05-17 | Children's Medical Center Corporation | Methods for promoting cell transfection (in vivo) |
US6419621B1 (en) | 1997-10-24 | 2002-07-16 | Radiomed Corporation | Coiled brachytherapy device |
US6030333A (en) * | 1997-10-24 | 2000-02-29 | Radiomed Corporation | Implantable radiotherapy device |
US6015541A (en) * | 1997-11-03 | 2000-01-18 | Micro Therapeutics, Inc. | Radioactive embolizing compositions |
US6270464B1 (en) * | 1998-06-22 | 2001-08-07 | Artemis Medical, Inc. | Biopsy localization method and device |
US6251418B1 (en) | 1997-12-18 | 2001-06-26 | C.R. Bard, Inc. | Systems and methods for local delivery of an agent |
ES2238543T3 (en) | 1997-12-29 | 2005-09-01 | Alza Corporation | ROAD FOR IMPLANT. |
US6451871B1 (en) | 1998-11-25 | 2002-09-17 | Novartis Ag | Methods of modifying surface characteristics |
EP1047337B1 (en) | 1998-01-14 | 2007-10-10 | Leonard Reiffel | System to stabilize an irradiated internal target |
US6181960B1 (en) * | 1998-01-15 | 2001-01-30 | University Of Virginia Patent Foundation | Biopsy marker device |
US6289229B1 (en) | 1998-01-20 | 2001-09-11 | Scimed Life Systems, Inc. | Readable probe array for in vivo use |
US6660010B2 (en) | 1998-01-27 | 2003-12-09 | Scimed Life Systems, Inc. | Bone anchor placement device with recessed anchor mount |
US6540693B2 (en) | 1998-03-03 | 2003-04-01 | Senorx, Inc. | Methods and apparatus for securing medical instruments to desired locations in a patients body |
US6053925A (en) | 1998-02-27 | 2000-04-25 | Barnhart; William H. | Lesion localization device and method |
US6471700B1 (en) | 1998-04-08 | 2002-10-29 | Senorx, Inc. | Apparatus and method for accessing biopsy site |
US6312429B1 (en) | 1998-09-01 | 2001-11-06 | Senorx, Inc. | Electrosurgical lesion location device |
US6638234B2 (en) | 1998-03-03 | 2003-10-28 | Senorx, Inc. | Sentinel node location and biopsy |
ATE397887T1 (en) | 1998-04-07 | 2008-07-15 | Cytyc Corp | DEVICES FOR LOCALIZING LESIONS IN SOLID TISSUE |
US6161034A (en) * | 1999-02-02 | 2000-12-12 | Senorx, Inc. | Methods and chemical preparations for time-limited marking of biopsy sites |
US6347241B2 (en) * | 1999-02-02 | 2002-02-12 | Senorx, Inc. | Ultrasonic and x-ray detectable biopsy site marker and apparatus for applying it |
US6447527B1 (en) | 1998-04-23 | 2002-09-10 | Ronald J. Thompson | Apparatus and methods for the penetration of tissue |
US6610026B2 (en) | 1998-05-01 | 2003-08-26 | Sub-Q, Inc. | Method of hydrating a sponge material for delivery to a body |
US20010045575A1 (en) | 1998-05-01 | 2001-11-29 | Mark Ashby | Device and method for facilitating hemostasis of a biopsy tract |
US6363940B1 (en) | 1998-05-14 | 2002-04-02 | Calypso Medical Technologies, Inc. | System and method for bracketing and removing tissue |
US6224630B1 (en) * | 1998-05-29 | 2001-05-01 | Advanced Bio Surfaces, Inc. | Implantable tissue repair device |
US6159143A (en) * | 1998-06-17 | 2000-12-12 | Scimed Life Systems, Inc. | Method and device for delivery of therapeutic agents in conjunction with isotope seed placement |
US20020058882A1 (en) * | 1998-06-22 | 2002-05-16 | Artemis Medical, Incorporated | Biopsy localization method and device |
DE59913189D1 (en) | 1998-06-25 | 2006-05-04 | Biotronik Ag | Implantable, bioabsorbable vessel wall support, in particular coronary stent |
US6261302B1 (en) * | 1998-06-26 | 2001-07-17 | Ethicon Endo-Surgery, Inc. | Applier for implantable surgical marker |
US5941890A (en) | 1998-06-26 | 1999-08-24 | Ethicon Endo-Surgery, Inc. | Implantable surgical marker |
US5921933A (en) | 1998-08-17 | 1999-07-13 | Medtronic, Inc. | Medical devices with echogenic coatings |
US6179860B1 (en) | 1998-08-19 | 2001-01-30 | Artemis Medical, Inc. | Target tissue localization device and method |
CA2340251C (en) | 1998-08-21 | 2005-01-04 | Providence Health System-Oregon | Insertable stent and methods of making and using same |
US6335029B1 (en) | 1998-08-28 | 2002-01-01 | Scimed Life Systems, Inc. | Polymeric coatings for controlled delivery of active agents |
US6159240A (en) | 1998-08-31 | 2000-12-12 | Medtronic, Inc. | Rigid annuloplasty device that becomes compliant after implantation |
US6936014B2 (en) | 2002-10-16 | 2005-08-30 | Rubicor Medical, Inc. | Devices and methods for performing procedures on a breast |
US6656192B2 (en) | 1998-09-25 | 2003-12-02 | United States Surgical Corporatioin | Site marker device |
US6056700A (en) | 1998-10-13 | 2000-05-02 | Emx, Inc. | Biopsy marker assembly and method of use |
EP0993843B1 (en) | 1998-10-14 | 2006-04-26 | Terumo Kabushiki Kaisha | Radiation source delivery wire and catheter assembly for radiation therapy |
US6220248B1 (en) * | 1998-10-21 | 2001-04-24 | Ethicon Endo-Surgery, Inc. | Method for implanting a biopsy marker |
WO2000023124A1 (en) | 1998-10-22 | 2000-04-27 | Edwards Lifesciences Corporation | Multi-functional coatings for medical devices |
US6951564B2 (en) | 1998-10-23 | 2005-10-04 | United States Surgical Corporation | Site marker device |
AU1126500A (en) | 1998-10-23 | 2000-05-15 | Armand F. Cortese | Marker for indicating the location of identified tissue |
US7844319B2 (en) | 1998-11-04 | 2010-11-30 | Susil Robert C | Systems and methods for magnetic-resonance-guided interventional procedures |
ATE319166T1 (en) | 1998-11-06 | 2006-03-15 | Ge Healthcare Ltd | DEVICES AND METHODS FOR BRACHYTHERAPY |
US6356782B1 (en) * | 1998-12-24 | 2002-03-12 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
US6371904B1 (en) * | 1998-12-24 | 2002-04-16 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
US6270472B1 (en) | 1998-12-29 | 2001-08-07 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Apparatus and a method for automatically introducing implants into soft tissue with adjustable spacing |
US8282573B2 (en) * | 2003-02-24 | 2012-10-09 | Senorx, Inc. | Biopsy device with selectable tissue receiving aperture orientation and site illumination |
US8498693B2 (en) | 1999-02-02 | 2013-07-30 | Senorx, Inc. | Intracorporeal marker and marker delivery device |
US8361082B2 (en) | 1999-02-02 | 2013-01-29 | Senorx, Inc. | Marker delivery device with releasable plug |
US6862470B2 (en) | 1999-02-02 | 2005-03-01 | Senorx, Inc. | Cavity-filling biopsy site markers |
US7651505B2 (en) * | 2002-06-17 | 2010-01-26 | Senorx, Inc. | Plugged tip delivery for marker placement |
US20090216118A1 (en) | 2007-07-26 | 2009-08-27 | Senorx, Inc. | Polysaccharide markers |
US20080039819A1 (en) | 2006-08-04 | 2008-02-14 | Senorx, Inc. | Marker formed of starch or other suitable polysaccharide |
US6725083B1 (en) * | 1999-02-02 | 2004-04-20 | Senorx, Inc. | Tissue site markers for in VIVO imaging |
US7983734B2 (en) * | 2003-05-23 | 2011-07-19 | Senorx, Inc. | Fibrous marker and intracorporeal delivery thereof |
JP3720999B2 (en) | 1999-02-18 | 2005-11-30 | 沖電気工業株式会社 | Input protection circuit |
US6200258B1 (en) | 1999-08-10 | 2001-03-13 | Syntheon, Llc | Radioactive therapeutic seed having selective marker configuration |
US6482143B1 (en) * | 1999-02-28 | 2002-11-19 | Syntheon, Llc | Raidoactive therapeutic seed having selective marker configuration |
US6173715B1 (en) | 1999-03-01 | 2001-01-16 | Lucent Medical Systems, Inc. | Magnetic anatomical marker and method of use |
US6144875A (en) | 1999-03-16 | 2000-11-07 | Accuray Incorporated | Apparatus and method for compensating for respiratory and patient motion during treatment |
CA2364570A1 (en) | 1999-04-09 | 2000-10-19 | The Regents Of The University Of Michigan | Preparing porous hydrogel products |
GB9909801D0 (en) | 1999-04-28 | 1999-06-23 | Btg Int Ltd | Ultrasound detectable instrument |
US6712836B1 (en) * | 1999-05-13 | 2004-03-30 | St. Jude Medical Atg, Inc. | Apparatus and methods for closing septal defects and occluding blood flow |
US20060247665A1 (en) | 1999-05-28 | 2006-11-02 | Ferree Bret A | Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft |
WO2000074565A1 (en) | 1999-06-05 | 2000-12-14 | Wilson-Cook Medical Inc. | Indicia for an endoscopic medical device |
US6066122A (en) | 1999-06-09 | 2000-05-23 | Fisher; John | Needle apparatus and method for marking lesions |
US6766186B1 (en) * | 1999-06-16 | 2004-07-20 | C. R. Bard, Inc. | Post biospy tissue marker and method of use |
US6575991B1 (en) | 1999-06-17 | 2003-06-10 | Inrad, Inc. | Apparatus for the percutaneous marking of a lesion |
US6626899B2 (en) | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
WO2001008578A1 (en) * | 1999-07-30 | 2001-02-08 | Vivant Medical, Inc. | Device and method for safe location and marking of a cavity and sentinel lymph nodes |
US6234177B1 (en) * | 1999-08-12 | 2001-05-22 | Thomas Barsch | Apparatus and method for deploying an expandable biopsy marker |
US6250307B1 (en) | 1999-09-17 | 2001-06-26 | Pi Medical, Inc. | Snoring treatment |
US8239001B2 (en) | 2003-10-17 | 2012-08-07 | Medtronic Navigation, Inc. | Method and apparatus for surgical navigation |
JP2001161838A (en) | 1999-12-07 | 2001-06-19 | Radiomed Corp | Wire-like radiation source member for cancer treatment and feeding device of the same |
US6450937B1 (en) | 1999-12-17 | 2002-09-17 | C. R. Bard, Inc. | Needle for implanting brachytherapy seeds |
US6899731B2 (en) | 1999-12-30 | 2005-05-31 | Boston Scientific Scimed, Inc. | Controlled delivery of therapeutic agents by insertable medical devices |
EP1114618A3 (en) | 2000-01-04 | 2001-08-22 | Ethicon Endo-Surgery, Inc. | Surgical instrument for applying beads to tissue |
US6506156B1 (en) | 2000-01-19 | 2003-01-14 | Vascular Control Systems, Inc | Echogenic coating |
US6575888B2 (en) * | 2000-01-25 | 2003-06-10 | Biosurface Engineering Technologies, Inc. | Bioabsorbable brachytherapy device |
CA2366813A1 (en) | 2000-01-26 | 2001-08-02 | Heartport, Inc. | Vascular incisor and method |
US6358217B1 (en) | 2000-01-31 | 2002-03-19 | Hugh Bourassa | Automatic and semi-automatic disposable biopsy needle device |
US6436030B2 (en) | 2000-01-31 | 2002-08-20 | Om P. Rehil | Hiatal hernia repair patch and method for using the same |
US6241687B1 (en) | 2000-02-18 | 2001-06-05 | Ethicon Endo-Surgery, Inc. | Method of use for a biopsy instrument with breakable sample segments |
EP1259155B1 (en) | 2000-02-18 | 2010-12-08 | Fogarty, Thomas J. | Improved device for accurately marking tissue |
US6564806B1 (en) | 2000-02-18 | 2003-05-20 | Thomas J. Fogarty | Device for accurately marking tissue |
US6350244B1 (en) * | 2000-02-21 | 2002-02-26 | Biopsy Sciences, Llc | Bioabsorable markers for use in biopsy procedures |
US6770070B1 (en) | 2000-03-17 | 2004-08-03 | Rita Medical Systems, Inc. | Lung treatment apparatus and method |
US6450938B1 (en) | 2000-03-21 | 2002-09-17 | Promex, Llc | Brachytherapy device |
US6356112B1 (en) | 2000-03-28 | 2002-03-12 | Translogic Technology, Inc. | Exclusive or/nor circuit |
US6628982B1 (en) | 2000-03-30 | 2003-09-30 | The Regents Of The University Of Michigan | Internal marker device for identification of biological substances |
WO2001074251A2 (en) | 2000-03-31 | 2001-10-11 | Rita Medical Systems Inc. | Tissue biopsy and treatment apparatus and method |
US6425903B1 (en) | 2000-05-09 | 2002-07-30 | James W. Voegele | Implantable surgical marker |
US6776796B2 (en) | 2000-05-12 | 2004-08-17 | Cordis Corportation | Antiinflammatory drug and delivery device |
US7419678B2 (en) | 2000-05-12 | 2008-09-02 | Cordis Corporation | Coated medical devices for the prevention and treatment of vascular disease |
AU7488001A (en) * | 2000-05-22 | 2001-12-03 | Verion Inc | Method for increasing the compressibility of poorly binding powder materials |
US6544231B1 (en) | 2000-05-22 | 2003-04-08 | Medcanica, Inc. | Catch, stop and marker assembly for a medical instrument and medical instrument incorporating the same |
US6961608B2 (en) | 2000-06-05 | 2005-11-01 | Kabushiki Kaisha Toshiba | Interventional MR imaging with detection and display of device position |
US6991652B2 (en) | 2000-06-13 | 2006-01-31 | Burg Karen J L | Tissue engineering composite |
US20020077693A1 (en) | 2000-12-19 | 2002-06-20 | Barclay Bruce J. | Covered, coiled drug delivery stent and method |
US6394965B1 (en) * | 2000-08-15 | 2002-05-28 | Carbon Medical Technologies, Inc. | Tissue marking using biocompatible microparticles |
WO2002024114A2 (en) * | 2000-09-25 | 2002-03-28 | Cohesion Technologies, Inc. | Resorbable anastomosis stents and plugs |
US6716444B1 (en) | 2000-09-28 | 2004-04-06 | Advanced Cardiovascular Systems, Inc. | Barriers for polymer-coated implantable medical devices and methods for making the same |
US6746773B2 (en) | 2000-09-29 | 2004-06-08 | Ethicon, Inc. | Coatings for medical devices |
US6863685B2 (en) | 2001-03-29 | 2005-03-08 | Cordis Corporation | Radiopacity intraluminal medical device |
US7261735B2 (en) | 2001-05-07 | 2007-08-28 | Cordis Corporation | Local drug delivery devices and methods for maintaining the drug coatings thereon |
US6712774B2 (en) | 2000-10-13 | 2004-03-30 | James W. Voegele | Lockout for a surgical biopsy device |
US6730044B2 (en) | 2000-10-13 | 2004-05-04 | Ethicon Endo-Surgery, Inc. | Firing mechanism for use in a surgical biopsy device |
US6540694B1 (en) | 2000-10-16 | 2003-04-01 | Sanarus Medical, Inc. | Device for biopsy tumors |
US6447524B1 (en) | 2000-10-19 | 2002-09-10 | Ethicon Endo-Surgery, Inc. | Fastener for hernia mesh fixation |
US6544185B2 (en) * | 2000-10-23 | 2003-04-08 | Valentino Montegrande | Ultrasound imaging marker and method of use |
CA2425665C (en) | 2000-10-31 | 2013-07-16 | Cook Incorporated | Coated implantable medical device |
US6758824B1 (en) | 2000-11-06 | 2004-07-06 | Suros Surgical Systems, Inc. | Biopsy apparatus |
US6746661B2 (en) * | 2000-11-16 | 2004-06-08 | Microspherix Llc | Brachytherapy seed |
CA2775170C (en) | 2000-11-20 | 2017-09-05 | Senorx, Inc. | An intracorporeal marker delivery system for marking a tissue site |
US20020077687A1 (en) | 2000-12-14 | 2002-06-20 | Ahn Samuel S. | Catheter assembly for treating ischemic tissue |
US6478790B2 (en) | 2000-12-22 | 2002-11-12 | Frank M. Bardani | Implant device and dosage form employable therein |
EP1363700A4 (en) | 2001-01-11 | 2005-11-09 | Rita Medical Systems Inc | Bone-treatment instrument and method |
US20020095205A1 (en) * | 2001-01-12 | 2002-07-18 | Edwin Tarun J. | Encapsulated radiopaque markers |
US6749627B2 (en) | 2001-01-18 | 2004-06-15 | Ev3 Peripheral, Inc. | Grip for stent delivery system |
US7014610B2 (en) | 2001-02-09 | 2006-03-21 | Medtronic, Inc. | Echogenic devices and methods of making and using such devices |
US6636758B2 (en) | 2001-05-01 | 2003-10-21 | Concentric Medical, Inc. | Marker wire and process for using it |
US6824527B2 (en) | 2001-06-07 | 2004-11-30 | Peter Gollobin | Protective sheath for winged needles and sheath and needle assembly |
US8197535B2 (en) | 2001-06-19 | 2012-06-12 | Cordis Corporation | Low profile improved radiopacity intraluminal medical device |
US6702744B2 (en) | 2001-06-20 | 2004-03-09 | Advanced Cardiovascular Systems, Inc. | Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery |
US7160258B2 (en) | 2001-06-26 | 2007-01-09 | Entrack, Inc. | Capsule and method for treating or diagnosing the intestinal tract |
US6648849B2 (en) | 2001-06-27 | 2003-11-18 | Ethicon, Inc. | Medicinal implant and device and method for loading and delivering implants containing drugs and cells |
US9861517B2 (en) | 2001-07-26 | 2018-01-09 | Cook Medical Technologies Llc | Vessel closure member, delivery apparatus, and method of inserting the member |
WO2003011161A1 (en) | 2001-08-03 | 2003-02-13 | Tyco Healthcare Group Lp | Tissue marking apparatus and method |
US6913626B2 (en) | 2001-08-14 | 2005-07-05 | Mcghan Jim J. | Medical implant having bioabsorbable textured surface |
US6605047B2 (en) | 2001-09-10 | 2003-08-12 | Vivant Medical, Inc. | Biopsy marker delivery system |
US7135978B2 (en) | 2001-09-14 | 2006-11-14 | Calypso Medical Technologies, Inc. | Miniature resonating marker assembly |
US7294118B2 (en) | 2001-10-24 | 2007-11-13 | Becton, Dickinson And Company | Retractable needle assembly |
US6939318B2 (en) | 2002-05-03 | 2005-09-06 | Boston Scientific Scimed, Inc. | Method, tool, and system for deploying an implant into the body |
US7280865B2 (en) | 2001-12-20 | 2007-10-09 | Accuray Incorporated | Anchored fiducial apparatus and method |
US8088388B2 (en) | 2002-02-14 | 2012-01-03 | United Biomedical, Inc. | Stabilized synthetic immunogen delivery system |
EP1494611A2 (en) | 2002-03-11 | 2005-01-12 | John L. Wardle | Surgical coils and methods of deploying |
US7527610B2 (en) | 2002-03-29 | 2009-05-05 | Bioform Medical, Inc. | Connection indicator for a medical delivery/extraction system |
US20040001841A1 (en) | 2002-04-03 | 2004-01-01 | Usha Nagavarapu | Use of biomolecular targets in the treatment and visualization of brain tumors |
US20030191355A1 (en) | 2002-04-04 | 2003-10-09 | Ferguson Patrick J. | Hollow bioabsorbable elements for positioning material in living tissue |
US6818668B2 (en) | 2002-04-12 | 2004-11-16 | Biotest Laboratories, Llc | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method |
US6652442B2 (en) | 2002-04-23 | 2003-11-25 | Acueity, Inc. | Micro-endoscope assembly for intraductal brachytherapy of a mammary duct and method of using same |
US20030199887A1 (en) | 2002-04-23 | 2003-10-23 | David Ferrera | Filamentous embolization device and method of use |
US7329414B2 (en) | 2002-05-03 | 2008-02-12 | Biopsy Sciences, Llc | Biodegradable polymer for marking tissue and sealing tracts |
US6780179B2 (en) | 2002-05-22 | 2004-08-24 | Rubicor Medical, Inc. | Methods and systems for in situ tissue marking and orientation stabilization |
US6992233B2 (en) | 2002-05-31 | 2006-01-31 | Medafor, Inc. | Material delivery system |
US7166133B2 (en) | 2002-06-13 | 2007-01-23 | Kensey Nash Corporation | Devices and methods for treating defects in the tissue of a living being |
US20040101548A1 (en) | 2002-11-26 | 2004-05-27 | Pendharkar Sanyog Manohar | Hemostatic wound dressing containing aldehyde-modified polysaccharide |
WO2004006976A1 (en) | 2002-07-12 | 2004-01-22 | Cook Incorporated | Coated medical device |
US20040016195A1 (en) | 2002-07-24 | 2004-01-29 | Archuleta John Paul | Foamed glass article for use as thermal energy control media |
EP1545316B1 (en) | 2002-08-01 | 2008-01-09 | James E. Selis | Biopsy devices |
WO2004020024A1 (en) | 2002-08-30 | 2004-03-11 | Inrad, Inc. | Localizing needle with fluid delivery |
US7103418B2 (en) | 2002-10-02 | 2006-09-05 | Medtronic, Inc. | Active fluid delivery catheter |
US7041047B2 (en) | 2002-10-04 | 2006-05-09 | Boston Scientific Scimed, Inc. | Method and apparatus for the delivery of brachytherapy |
US20040116802A1 (en) | 2002-10-05 | 2004-06-17 | Jessop Precision Products, Inc. | Medical imaging marker |
US8027712B2 (en) | 2002-10-11 | 2011-09-27 | Ion Beam Applications S.A. | Elongated markers for soft tissue volume identification |
US6994712B1 (en) | 2002-11-12 | 2006-02-07 | Biopsy Sciences, Llc | Bioabsorbable marker having external anchoring means |
EP2221019B1 (en) | 2002-11-18 | 2012-01-04 | Bard Peripheral Vascular, Inc. | Percutaneous imaging marker |
US20060036158A1 (en) | 2003-11-17 | 2006-02-16 | Inrad, Inc. | Self-contained, self-piercing, side-expelling marking apparatus |
US8137288B2 (en) | 2002-11-20 | 2012-03-20 | Boston Scientific Scimed, Inc. | Medical instrument |
US7008382B2 (en) | 2002-11-20 | 2006-03-07 | Scimed Life Systems, Inc. | Medical instrument |
US6889833B2 (en) | 2002-12-30 | 2005-05-10 | Calypso Medical Technologies, Inc. | Packaged systems for implanting markers in a patient and methods for manufacturing and using such systems |
US7247160B2 (en) | 2002-12-30 | 2007-07-24 | Calypso Medical Technologies, Inc. | Apparatuses and methods for percutaneously implanting objects in patients |
US20040133124A1 (en) | 2003-01-06 | 2004-07-08 | Cook Incorporated. | Flexible biopsy needle |
US9314235B2 (en) | 2003-02-05 | 2016-04-19 | Smith & Nephew, Inc. | Tissue anchor and insertion tool |
WO2004075789A2 (en) | 2003-02-26 | 2004-09-10 | Cook Incorporated | PROTHESIS ADAPTED FOR PLACEDd UNDER EXTERNAL IMAGING |
FR2853521B1 (en) | 2003-04-10 | 2005-12-02 | Claude Mialhe | DEVICE FOR EXPANDING A VESSEL AND INTRODUCING VASCULAR IMPLANT |
US8372112B2 (en) | 2003-04-11 | 2013-02-12 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods, and related methods of use |
US8383158B2 (en) | 2003-04-15 | 2013-02-26 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
US7306580B2 (en) | 2003-04-16 | 2007-12-11 | Cook Incorporated | Medical device with therapeutic agents |
US6945973B2 (en) | 2003-05-01 | 2005-09-20 | Nuvasive, Inc. | Slidable bone plate system |
US7877133B2 (en) | 2003-05-23 | 2011-01-25 | Senorx, Inc. | Marker or filler forming fluid |
US20050119562A1 (en) * | 2003-05-23 | 2005-06-02 | Senorx, Inc. | Fibrous marker formed of synthetic polymer strands |
US7783336B2 (en) | 2003-06-06 | 2010-08-24 | Ethicon Endo-Surgery, Inc. | Subcutaneous biopsy cavity marker device |
US20040253185A1 (en) | 2003-06-12 | 2004-12-16 | Atrium Medical Corp. | Medicated ink |
US7744852B2 (en) | 2003-07-25 | 2010-06-29 | Rubicor Medical, Llc | Methods and systems for marking post biopsy cavity sites |
US7537788B2 (en) | 2003-07-25 | 2009-05-26 | Rubicor Medical, Inc. | Post-biopsy cavity treatment implants and methods |
US20050033157A1 (en) | 2003-07-25 | 2005-02-10 | Klein Dean A. | Multi-modality marking material and method |
US20050049634A1 (en) | 2003-08-07 | 2005-03-03 | Scimed Life Systems, Inc. | Medical closure device |
US7790141B2 (en) | 2003-08-11 | 2010-09-07 | Pathak Holdings, Llc | Radio-opaque compounds, compositions containing same and methods of their synthesis and use |
US7001341B2 (en) | 2003-08-13 | 2006-02-21 | Scimed Life Systems, Inc. | Marking biopsy sites |
US20050059887A1 (en) * | 2003-09-16 | 2005-03-17 | Hassan Mostafavi | Localization of a target using in vivo markers |
WO2005037338A1 (en) | 2003-10-14 | 2005-04-28 | Cook Incorporated | Hydrophilic coated medical device |
US20050148512A1 (en) | 2003-11-10 | 2005-07-07 | Angiotech International Ag | Medical implants and fibrosis-inducing agents |
US20050273002A1 (en) | 2004-06-04 | 2005-12-08 | Goosen Ryan L | Multi-mode imaging marker |
US20050112151A1 (en) | 2003-11-20 | 2005-05-26 | Horng Liou L. | Skin adherent hydrogels |
JP2007514472A (en) | 2003-11-20 | 2007-06-07 | アンジオテック インターナショナル アーゲー | Soft tissue grafts and scarring inhibitors |
US20050113659A1 (en) | 2003-11-26 | 2005-05-26 | Albert Pothier | Device for data input for surgical navigation system |
WO2005053560A1 (en) | 2003-11-26 | 2005-06-16 | Invivo Germany Gmbh | Tissue marker and method and apparatus for deploying the marker |
US20050142161A1 (en) | 2003-12-30 | 2005-06-30 | Freeman Lynetta J. | Collagen matrix for soft tissue augmentation |
GB0405013D0 (en) | 2004-03-05 | 2004-04-07 | Depuy Int Ltd | Implantable marker instruments and methods |
US7761138B2 (en) | 2004-03-12 | 2010-07-20 | Boston Scientific Scimed, Inc. | MRI and X-ray visualization |
US7901707B2 (en) | 2004-03-15 | 2011-03-08 | Christine Allen | Biodegradable biocompatible implant and method of manufacturing same |
US20050234336A1 (en) | 2004-03-26 | 2005-10-20 | Beckman Andrew T | Apparatus and method for marking tissue |
US7959634B2 (en) | 2004-03-29 | 2011-06-14 | Soteira Inc. | Orthopedic surgery access devices |
ES2638301T3 (en) | 2004-05-14 | 2017-10-19 | Ethicon Llc | Suture devices |
US9638770B2 (en) | 2004-05-21 | 2017-05-02 | Devicor Medical Products, Inc. | MRI biopsy apparatus incorporating an imageable penetrating portion |
US8075568B2 (en) | 2004-06-11 | 2011-12-13 | Selis James E | Biopsy devices and methods |
DE102004030391A1 (en) | 2004-06-23 | 2006-01-26 | Somatex Medical Technologies Gmbh | marker |
EP1771223A4 (en) | 2004-07-23 | 2009-04-22 | Calypso Med Technologies Inc | Apparatuses and methods for percutaneously implanting objects in patients |
US20080097199A1 (en) | 2004-08-20 | 2008-04-24 | David Mullen | Tissue Marking Devices and Systems |
US8442623B2 (en) | 2004-10-13 | 2013-05-14 | Suros Surgical Systems, Inc. | Site marker visible under multiple modalities |
US20060079805A1 (en) * | 2004-10-13 | 2006-04-13 | Miller Michael E | Site marker visable under multiple modalities |
US8280486B2 (en) | 2004-10-13 | 2012-10-02 | Suros Surgical Systems, Inc. | Site marker visable under multiple modalities |
WO2006043582A1 (en) | 2004-10-22 | 2006-04-27 | Kaneka Corporation | Catheter for medical treatment |
US8419656B2 (en) | 2004-11-22 | 2013-04-16 | Bard Peripheral Vascular, Inc. | Post decompression marker introducer system |
WO2006056739A2 (en) | 2004-11-23 | 2006-06-01 | Quantum Medical Technology Limited | Surgical tag, magnetometer, and associated system |
US8334424B2 (en) | 2004-12-22 | 2012-12-18 | Principle Business Enterprises, Inc. | Animal incontinence device |
WO2006069677A2 (en) | 2004-12-30 | 2006-07-06 | Cinvention Ag | Combination comprising an agent providing a signal, an implant material and a drug |
US7577473B2 (en) | 2005-02-03 | 2009-08-18 | Bard Peripheral Vascular, Inc. | Apparatus for subcutaneous placement of an imaging marker |
DE102005012574A1 (en) | 2005-03-18 | 2006-09-21 | Bkh - Technotransfer Gmbh | Markers for animal and human tissue, in particular soft tissue |
US20060217635A1 (en) | 2005-03-24 | 2006-09-28 | Mccombs Elizabeth S | Biopsy device marker deployment |
US20060235298A1 (en) | 2005-03-31 | 2006-10-19 | Robert Kotmel | Internal biopsy marking |
US20060241385A1 (en) | 2005-04-12 | 2006-10-26 | Ethicon Endo-Surgery, Inc. | Guided disposable fiducial for breast biopsy localization fixture |
US10357328B2 (en) | 2005-04-20 | 2019-07-23 | Bard Peripheral Vascular, Inc. and Bard Shannon Limited | Marking device with retractable cannula |
CN101243332A (en) | 2005-06-21 | 2008-08-13 | 纳维斯堪Pet***有限公司 | Tissue interventions using nuclear-emission image guidance |
US20060292690A1 (en) | 2005-06-22 | 2006-12-28 | Cesco Bioengineering Co., Ltd. | Method of making cell growth surface |
US7736293B2 (en) | 2005-07-22 | 2010-06-15 | Biocompatibles Uk Limited | Implants for use in brachytherapy and other radiation therapy that resist migration and rotation |
US9498647B2 (en) | 2005-09-23 | 2016-11-22 | Allen B. Kantrowitz | Fiducial marker system for subject movement compensation during medical treatment |
ES2366102T3 (en) * | 2005-09-26 | 2011-10-17 | Bard Peripheral Vascular, Inc. | INTRODUCTION SYSTEM OF A MARKER AFTER DECOMPRESSION. |
US8052658B2 (en) | 2005-10-07 | 2011-11-08 | Bard Peripheral Vascular, Inc. | Drug-eluting tissue marker |
US20070083132A1 (en) | 2005-10-11 | 2007-04-12 | Sharrow James S | Medical device coil |
US8251963B2 (en) | 2005-12-08 | 2012-08-28 | Boston Scientific Scimed, Inc. | Flexible needle |
US7761137B2 (en) | 2005-12-16 | 2010-07-20 | Suros Surgical Systems, Inc. | Biopsy site marker deployment device |
US8118786B2 (en) | 2006-03-29 | 2012-02-21 | Kawasumi Laboratories, Inc. | Guarded medical winged needle assembly |
US20070276492A1 (en) | 2006-05-09 | 2007-11-29 | Ranier Limited | Artificial spinal disc implant |
US20070287933A1 (en) | 2006-06-08 | 2007-12-13 | Chris Phan | Tissue debulking device and method of using the same |
US20080294039A1 (en) * | 2006-08-04 | 2008-11-27 | Senorx, Inc. | Assembly with hemostatic and radiographically detectable pellets |
US7945307B2 (en) | 2006-08-04 | 2011-05-17 | Senorx, Inc. | Marker delivery system with obturator |
US20090171198A1 (en) | 2006-08-04 | 2009-07-02 | Jones Michael L | Powdered marker |
EP2079385B1 (en) | 2006-10-23 | 2013-11-20 | C.R.Bard, Inc. | Breast marker |
WO2008073965A2 (en) | 2006-12-12 | 2008-06-19 | C.R. Bard Inc. | Multiple imaging mode tissue marker |
WO2008076973A2 (en) | 2006-12-18 | 2008-06-26 | C.R.Bard Inc. | Biopsy marker with in situ-generated imaging properties |
US20080177179A1 (en) | 2006-12-19 | 2008-07-24 | Cytyc Corporation | Target Tissue Locator for Image Guided Radiotherapy |
US7704234B2 (en) | 2007-04-05 | 2010-04-27 | Darr Allan J | Dynaflex |
US8320995B2 (en) | 2007-04-26 | 2012-11-27 | Schwamb Jr John P | Fiducial marker with rings |
US20090024225A1 (en) * | 2007-07-16 | 2009-01-22 | Stubbs James B | Implant for Targeting Therapeutic Procedure |
US8311610B2 (en) | 2008-01-31 | 2012-11-13 | C. R. Bard, Inc. | Biopsy tissue marker |
EP2156806A1 (en) | 2008-08-18 | 2010-02-24 | Navotek Medical Ltd. | Implantation device for soft tissue markers and other implants |
US9327061B2 (en) | 2008-09-23 | 2016-05-03 | Senorx, Inc. | Porous bioabsorbable implant |
US7978825B2 (en) | 2008-10-13 | 2011-07-12 | Mdx Laboratories, Llc | Anatomical marker for x-ray orientation |
US8670818B2 (en) | 2008-12-30 | 2014-03-11 | C. R. Bard, Inc. | Marker delivery device for tissue marker placement |
US20100204570A1 (en) | 2009-02-06 | 2010-08-12 | Paul Lubock | Anchor markers |
US20120078087A1 (en) | 2010-09-23 | 2012-03-29 | Curry Kyle S | Tissue Localization Device and Method |
US8554309B2 (en) | 2010-09-23 | 2013-10-08 | Hologic, Inc. | Localizing obturator with site marking capability |
-
2008
- 2008-02-21 US US12/070,787 patent/US20090216118A1/en not_active Abandoned
- 2008-02-21 US US12/070,786 patent/US20090030309A1/en not_active Abandoned
-
2009
- 2009-02-13 JP JP2010547619A patent/JP2011516408A/en not_active Ceased
- 2009-02-13 WO PCT/US2009/000945 patent/WO2009105177A1/en active Application Filing
- 2009-02-13 AU AU2009215896A patent/AU2009215896B2/en not_active Ceased
- 2009-02-13 CA CA2715743A patent/CA2715743A1/en not_active Abandoned
- 2009-02-13 CN CN2009801096723A patent/CN101977561A/en active Pending
- 2009-02-13 EP EP09712596A patent/EP2244653A1/en not_active Withdrawn
-
2011
- 2011-11-21 US US13/301,297 patent/US20120078092A1/en not_active Abandoned
- 2011-11-21 US US13/301,024 patent/US9149341B2/en not_active Expired - Fee Related
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2899362A (en) * | 1959-08-11 | Hemostatic sponges and method of | ||
US3005457A (en) * | 1957-04-01 | 1961-10-24 | Ortho Pharma Corp | Methyl cellulose sponge and method of making |
US4950234A (en) * | 1987-05-26 | 1990-08-21 | Sumitomo Pharmaceuticals Company, Limited | Device for administering solid preparations |
US5035891A (en) * | 1987-10-05 | 1991-07-30 | Syntex (U.S.A.) Inc. | Controlled release subcutaneous implant |
US6350274B1 (en) * | 1992-05-11 | 2002-02-26 | Regen Biologics, Inc. | Soft tissue closure systems |
US5281197A (en) * | 1992-07-27 | 1994-01-25 | Symbiosis Corporation | Endoscopic hemostatic agent delivery system |
US5405402A (en) * | 1993-04-14 | 1995-04-11 | Intermedics Orthopedics, Inc. | Implantable prosthesis with radiographic marker |
US6228055B1 (en) * | 1994-09-16 | 2001-05-08 | Ethicon Endo-Surgery, Inc. | Devices for marking and defining particular locations in body tissue |
US6288055B1 (en) * | 1998-06-08 | 2001-09-11 | Advanced Medicine, Inc. | Analgesic agents |
US6554760B2 (en) * | 2000-10-25 | 2003-04-29 | Gary A. Lamoureux | Pre-loaded needle assembly |
US20020188195A1 (en) * | 2001-06-07 | 2002-12-12 | Mills Stanley L. | Echogenic medical device |
US20040265371A1 (en) * | 2003-06-25 | 2004-12-30 | Looney Dwayne Lee | Hemostatic devices and methods of making same |
Cited By (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9480554B2 (en) | 1997-10-10 | 2016-11-01 | Senorx, Inc. | Tissue marking implant |
US9039763B2 (en) | 1997-10-10 | 2015-05-26 | Senorx, Inc. | Tissue marking implant |
US10058416B2 (en) | 1997-10-10 | 2018-08-28 | Senorx, Inc. | Tissue marking implant |
US8668737B2 (en) | 1997-10-10 | 2014-03-11 | Senorx, Inc. | Tissue marking implant |
US10172674B2 (en) | 1999-02-02 | 2019-01-08 | Senorx, Inc. | Intracorporeal marker and marker delivery device |
US9649093B2 (en) | 1999-02-02 | 2017-05-16 | Senorx, Inc. | Cavity-filling biopsy site markers |
US9237937B2 (en) | 1999-02-02 | 2016-01-19 | Senorx, Inc. | Cavity-filling biopsy site markers |
US9149341B2 (en) | 1999-02-02 | 2015-10-06 | Senorx, Inc | Deployment of polysaccharide markers for treating a site within a patient |
US8626270B2 (en) | 1999-02-02 | 2014-01-07 | Senorx, Inc. | Cavity-filling biopsy site markers |
US9861294B2 (en) | 1999-02-02 | 2018-01-09 | Senorx, Inc. | Marker delivery device with releasable plug |
US9044162B2 (en) | 1999-02-02 | 2015-06-02 | Senorx, Inc. | Marker delivery device with releasable plug |
US8965486B2 (en) | 1999-02-02 | 2015-02-24 | Senorx, Inc. | Cavity filling biopsy site markers |
US9579159B2 (en) | 1999-06-17 | 2017-02-28 | Bard Peripheral Vascular, Inc. | Apparatus for the percutaneous marking of a lesion |
US10463446B2 (en) | 1999-06-17 | 2019-11-05 | Bard Peripheral Vascular, Inc. | Apparatus for the percutaneous marking of a lesion |
US8718745B2 (en) | 2000-11-20 | 2014-05-06 | Senorx, Inc. | Tissue site markers for in vivo imaging |
US8784433B2 (en) | 2002-06-17 | 2014-07-22 | Senorx, Inc. | Plugged tip delivery tube for marker placement |
US20050189192A1 (en) * | 2002-09-12 | 2005-09-01 | Luk Lamellen Und Kupplungsbau Beteiligungs Kg | Method for reducing juddering vibrations |
US10813716B2 (en) | 2002-11-18 | 2020-10-27 | Bard Peripheral Vascular, Inc. | Self-contained, self-piercing, side-expelling marking apparatus |
US9848956B2 (en) | 2002-11-18 | 2017-12-26 | Bard Peripheral Vascular, Inc. | Self-contained, self-piercing, side-expelling marking apparatus |
US10045832B2 (en) | 2003-05-23 | 2018-08-14 | Senorx, Inc. | Marker or filler forming fluid |
US8639315B2 (en) | 2003-05-23 | 2014-01-28 | Senorx, Inc. | Marker or filler forming fluid |
US8626269B2 (en) | 2003-05-23 | 2014-01-07 | Senorx, Inc. | Fibrous marker and intracorporeal delivery thereof |
US8880154B2 (en) | 2003-05-23 | 2014-11-04 | Senorx, Inc. | Fibrous marker and intracorporeal delivery thereof |
US9801688B2 (en) | 2003-05-23 | 2017-10-31 | Senorx, Inc. | Fibrous marker and intracorporeal delivery thereof |
US10299881B2 (en) | 2003-05-23 | 2019-05-28 | Senorx, Inc. | Marker or filler forming fluid |
US8634899B2 (en) | 2003-11-17 | 2014-01-21 | Bard Peripheral Vascular, Inc. | Multi mode imaging marker |
US10342635B2 (en) | 2005-04-20 | 2019-07-09 | Bard Peripheral Vascular, Inc. | Marking device with retractable cannula |
US11278370B2 (en) | 2005-04-20 | 2022-03-22 | Bard Peripheral Vascular, Inc. | Marking device with retractable cannula |
US10357328B2 (en) | 2005-04-20 | 2019-07-23 | Bard Peripheral Vascular, Inc. and Bard Shannon Limited | Marking device with retractable cannula |
US9901415B2 (en) | 2006-12-12 | 2018-02-27 | C. R. Bard, Inc. | Multiple imaging mode tissue marker |
US11471244B2 (en) | 2006-12-12 | 2022-10-18 | C.R. Bard, Inc. | Multiple imaging mode tissue marker |
US9579077B2 (en) | 2006-12-12 | 2017-02-28 | C.R. Bard, Inc. | Multiple imaging mode tissue marker |
US10682200B2 (en) | 2006-12-12 | 2020-06-16 | C. R. Bard, Inc. | Multiple imaging mode tissue marker |
US9042965B2 (en) | 2006-12-18 | 2015-05-26 | C. R. Bard, Inc. | Biopsy marker with in situ-generated imaging properties |
US10786604B2 (en) | 2008-09-23 | 2020-09-29 | Senorx, Inc. | Porous bioabsorbable implant |
US11833275B2 (en) | 2008-09-23 | 2023-12-05 | Senorx, Inc. | Porous bioabsorbable implant |
US10258428B2 (en) | 2008-12-30 | 2019-04-16 | C. R. Bard, Inc. | Marker delivery device for tissue marker placement |
US11779431B2 (en) | 2008-12-30 | 2023-10-10 | C. R. Bard, Inc. | Marker delivery device for tissue marker placement |
USD716450S1 (en) | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD716451S1 (en) | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD715942S1 (en) | 2013-09-24 | 2014-10-21 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD715442S1 (en) | 2013-09-24 | 2014-10-14 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
US10683119B2 (en) | 2014-05-23 | 2020-06-16 | Merit Medical Systems, Inc. | Marker element, device for making a marker element, and method for making a marker element |
Also Published As
Publication number | Publication date |
---|---|
US20090030309A1 (en) | 2009-01-29 |
AU2009215896A1 (en) | 2009-08-27 |
WO2009105177A1 (en) | 2009-08-27 |
US20090216118A1 (en) | 2009-08-27 |
CN101977561A (en) | 2011-02-16 |
US9149341B2 (en) | 2015-10-06 |
EP2244653A1 (en) | 2010-11-03 |
US20120116215A1 (en) | 2012-05-10 |
AU2009215896B2 (en) | 2013-09-12 |
CA2715743A1 (en) | 2009-08-27 |
JP2011516408A (en) | 2011-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9149341B2 (en) | Deployment of polysaccharide markers for treating a site within a patient | |
US9820824B2 (en) | Deployment of polysaccharide markers for treating a site within a patent | |
US9801688B2 (en) | Fibrous marker and intracorporeal delivery thereof | |
US20080294039A1 (en) | Assembly with hemostatic and radiographically detectable pellets | |
US20090171198A1 (en) | Powdered marker | |
US20080039819A1 (en) | Marker formed of starch or other suitable polysaccharide | |
US9861294B2 (en) | Marker delivery device with releasable plug | |
US20050119562A1 (en) | Fibrous marker formed of synthetic polymer strands | |
US10172674B2 (en) | Intracorporeal marker and marker delivery device | |
EP1811915A1 (en) | Fibrous marker formed of synthetic polymer strands |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SENORX, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:JONES, MICHAEL L.;LUBOCK, PAUL;SIGNING DATES FROM 20110923 TO 20111031;REEL/FRAME:027260/0199 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |